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ABSTRACT 
Inflammatory bowel disease (IBD) is an idiopathic, severe disease, which is characterized by 
chronic inflammation of the gastrointestinal tract. The incidence of IBD has increased through 
the last decades and specially among the pediatric population. The time from onset of 
symptoms to a final diagnose is made, is often related to delays and for many patients it is an 
emotionally demanding process. Early investigation in suspected cases may reduce the delay 
so that a treatment can begin as soon as possible. The involvement of intestinal microflora for 
pathogenesis of IBD is a link to further investigations to understand the disease, and to help 
people who suffer from IBD. The aim of the present work was to distinguish between 
pediatric IBD and non-IBD by identifying signatures in the microbiota. This was 
accomplished by use of a diagnostic tool based on GA-mapTM technology and the use of 
single nucleotide primer extension (SNuPE) probes to search for complementary bacterial 
16S rRNA gene sequences. Seventy-four feces samples were collected from cohort and tested 
against 77 SNuPE probes. Statistical analysis was performed with Partial Least Squares – 
Discriminant Analysis and presented specificity by 82 % and sensitivity by 86 %. 
Classification error presented 16 % and indicated how many that was misclassified by the 
model. Inflammatory bowel disease is considered to include two major disorders where 
Crohn’s disease is one of them, and best correlation was found between Crohn’s disease and 
non-IBD through statistical analysis. Common bacteria that are normally shared among 
people with a healthy intestinal were obtained from the cohort, and as a conclusion seems an 
alteration of common bacteria to be involved in Crohn’s disease. 
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1.2 Glossary  
 
Term Explanation Reference 
Antigen All substance or structures that is capable to be 
recognized of the immune system (e.g. bacterium 
or virus). 
(Lea, 2006) 
 
Biopsy The removal and examination of tissue from the 
living body. 
(Dorlands, 1981) 
Colonoscopy An elongated flexible endoscopy, which permits 
visual examination of the entire colon. 
(Dorlands, 1981) 
Commensal An organism living on or within another, but not 
causing injury to the host.  
(Dorlands, 1981) 
Dysbiosis A condition of microbial imbalance. (Matarese & Kandil, 2012) 
Endoscopy Visual inspection of any cavity of the body by 
means of an endoscope. 
(Dorlands, 1981) 
Enteric Pertaining to the small intestine. (Dorlands, 1981) 
Epithelium The covering of internal and external surfaces of 
the body including the lining of vessels and other 
small cavities. 
(Dorlands, 1981) 
Idiopathic Of the nature of an idiopathy; self-originated, of 
unknown causation. 
(Dorlands, 1981) 
Infection Disease caused by pathogenic microorganisms. (Granum, 2007) 
Inflammation A localized protective response elicited by injury 
or destruction of tissues, which serves to destroy, 
dilute, or wall of both the injurious agent and the 
injured tissue.  
(Dorlands, 1981) 
Luminal Pertaining to the lumen of a tubular structure. (Dorlands, 1981) 
Mucosa A mucous membrane.  (Dorlands, 1981) 
NOD2/CARD15 CARD15, the gene product of the protein NOD2. 
Pattern recognition receptor, belonging to the 
human innate immunity. 
(Joossens et al., 2011; Schreiber, 
P., Albrecht, Hampe, & Krawczak, 
2005) 
Pathogen Any disease-producing microorganism. (Dorlands, 1981) 
Pathogenesis The development of morbid conditions or of 
disease; more specifically the cellular events and 
reactions and other pathologic mechanisms 
occurring in the development of disease. 
(Dorlands, 1981) 
Pediatric 
population 
Children up to 18 years.  (Perminow, Brackmann, et al., 
2009) 
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1.3 Abbreviations  
 
16S  16 Svedberg 
Ahus Akershus University Hospital 
bp Base pair 
CARD15 Caspase recruitment domain family, member 15 
CD Crohn’s disease 
DNA Deoxy Ribonucleic Acid 
GA Genetic Analysis AS 
GI Gastrointestinal 
IBD Inflammatory bowel disease 
IBDU Inflammatory bowel disease unclassified 
IBSEN-II Inflammatory Bowel South Eastern Norway-II 
NOD2 Nucleotide binding oligomerization domain 2 
Non-IBD Patients not having IBD (systematic controls) 
PC Principal component 
PCA Principal component analysis 
PCR Polymerase chain reaction 
PLS-DA Partial Least Squares - Discriminant Analysis 
rRNA Ribosomal Ribo Nucleic Acid  
SNuPE Single nucleotide primer extension 
Tm Melting temperature 
UC Ulcerative colitis 
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1.4 Problem description and aim of the thesis  !
Crohn’s disease (CD) and ulcerative colitis (UC) are known as the two main disorders for 
inflammatory bowel disease (IBD). IBD is characterized by relapse of chronic inflammation 
of the gastrointestinal (GI) tract (Baumgart & Carding, 2007; Mikhailov & Furner, 2009). The 
incidence among the pediatric population has increased during the last decades (Bousvaros et 
al., 2006; Escher et al., 2005), and debut during the first years of life is often associated with a 
widespread disease and presents severe and aggressive problems in the upcoming years 
(Nieuwenhuis & Escher, 2008; Perminow, Reikvam, et al., 2009). Why some people develop 
IBD is still an unanswered question, although it is fairly understood that there are complex 
interactions between immunological factors, bacterial factors and environmental triggers in 
genetic predisposed individuals (Baumgart & Carding, 2007; Bousvaros, et al., 2006; 
Mikhailov & Furner, 2009). The intestinal microflora is complicated and a complete survey is 
impossible. However, there are numerous studies of IBD that shows the involvement of 
intestinal microflora in the pathogenesis of IBD (Bousvaros, et al., 2006) and further 
investigations are important. 
 
One fifth goes to their doctor with intestinal problems (Knobel, 2011) but IBD is not the 
cause for all intestinal problems that occurs. There are also several cases where a definitive 
diagnosis between CD and UC initially could not be completed and where re-evaluation of 
diagnosis are needed (Mikhailov & Furner, 2009; Ravikumara & Sandhu, 2006). To 
distinguish between IBD and non-IBD are in many situations a long and comprehensive task, 
and the disease may have evolved during the time, before the disease is revealed. Based on 
these observations there is need to develop a diagnostic tool that reveals signs in an early 
stage of the disease course and to preclude or confirm IBD.  
 
By investigations performed by Genetic Analysis, there was found an overview of GI bacteria 
as potential biologic markers in diagnostics of IBD (Frøyland, 2010), and an evaluation where 
children feces samples highlighted the biodiversity of the gut microbiota (Nwosu, 2011). It is 
now feasible to take the next step to develop a diagnostic tool that reveals signs in the 
pathogenesis of pediatric IBD. The aim for this thesis was to distinguish between children 
with IBD and non-IBD by identifying signatures in the microbiota. This was accomplished by 
studying bacteria directed against core bacteria among healthy people, intestinal bacteria for 
infant, and bacteria correlated to IBD. A diagnostic tool related to bacteria correlating to IBD 
! "$!!
was to be designed in this thesis, to see if this could reveal more bacteria related to IBD 
compared to core and infant bacteria. This was to be performed by the use of a diagnostic tool 
based on GA-mapTM technology and the use of single nucleotide primer extension (SNuPE) 
probes to search for complementary bacterial 16S rRNA gene sequences. By identifying 
signatures for bacteria that correlated for IBD in an early stage, this could be an opportunity 
to reveal a sign for IBD, and to further start a treatment as soon as possible to prevent the 
development of the disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! %!!!
2 THE HUMAN GUT MICROBIOTA 
The majority of microbes reside in the gut have an influence on human physiology, nutrition 
and well-being. To understand the impact of gut microbes on human health it is necessary to 
decipher the content, diversity and function of the microbial gut community (Qin et al., 2010). 
The human gastrointestinal (GI) tract is essential for human life because of its involvement 
for supplying the human body with nutrients and energy sources through absorption of food 
(Zoetendal, Rajilic-Stojanovic, & Vos, 2008). Moreover, is microbes in the GI responsible for 
polysaccharide hydrolysis and fermentation, vitamin production, immune system stimulation, 
modulation of gut motility, and protection of human host from pathogen invasion (Agans et 
al., 2011). 
 
The intestinal microflora constitute a complex ecosystem with four bacterial divisions who 
dominate (represents more than 99 %), these are Firmicutes, Bacteroidetes, Proteobacteria and 
Actinobacteria (Sartor, 2008). 1014 bacteria of more than 1,000 different species and 
subspecies colonize the mucosal surface of the human GI tract (Cucchiara, Iebba, Conte, & 
Schippa, 2009) and the task to survey the whole gut seems almost impossible. A stable 
bacterial flora is first established after the child has turned 3 years (Baumgart & Carding, 
2007; Cucchiara, et al., 2009; Palmer, Bik, DiGiulio, Relman, & Brown, 2007) but the 
microflora of adolescent children seems to be different from that of adults (Agans, et al., 
2011). An establishment is influenced by microbial and host interactions and by external and 
internal factors (Cucchiara, et al., 2009; Fanaro, Chierici, Guerrini, & Vigi, 2003) and can 
therefore be quite individually. Despite individual differences, humans share a common core 
of microbes (Zoetendal, et al., 2008). The given total number of microbes over the GI tract is 
hard to imagine. A complex community and individual specific composition among people, 
complicates establishing links between the microbiota and intestinal disorders that can occur 
in the GI tract (Zoetendal, et al., 2008). 
 
There are numerous studies of inflammatory bowel disease (IBD) that confirms the 
involvement of intestinal microflora in the pathogenesis of IBD (Bousvaros, et al., 2006), but 
the pathogenesis remains poorly understood (Schwiertz et al., 2010; Shikhare & Kugathasan, 
2010). Whether the observed dysbiosis is either a cause or a consequence of the disease 
remains unclear (Baumgart & Carding, 2007; Joossens, et al., 2011), even though much point 
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in the direction that an altered configuration of the microflora may be a consequence rather 
than a cause (Sartor, 2008, 2011).  
 
3 INFLAMMATORY BOWEL DISEASE 
Crohn’s disease (CD) and ulcerative colitis (UC) are known as the two main disorders of 
inflammatory bowel disease. Why some people develop IBD is still an unanswered question, 
although it is fairly understood that there are complex interactions of various factors 
contributing to the disease (Baumgart & Carding, 2007; Bousvaros, et al., 2006; Mikhailov & 
Furner, 2009). Through the last decades there have been observed an increased incidence of 
IBD among the pediatric population (Bousvaros, et al., 2006; Escher, et al., 2005) and several 
epidemiological studies reports that particular CD has increased (Escher, et al., 2005). Debut 
during the early years of life is associated with a widespread disease and more aggressive and 
severe problems in the upcoming years (Nieuwenhuis & Escher, 2008; Perminow, Reikvam, 
et al., 2009). Children have fewer environmental cofounders and are considered as a more 
“clean” population, which is an advantage in terms of revealing the disease. Tracking IBD in 
the early years of life is therefor important, to reveal the natural history of the disease 
(Bousvaros, et al., 2006; Hait, Bousvaros, & Grand, 2005). 
 
3.1 Epidemiology !
Studying epidemiology can be important to get closer to a solution to why IBD develops in 
terms of where it occurs, whom the disease affects and when it occurs (Bousvaros, et al., 
2006). Highest incidences of IBD are reported from developed countries (Baumgart & 
Carding, 2007; Ravikumara & Sandhu, 2006; Russel, 2000), and children with IBD accounts 
for nearly 30 % of the total cases (Escher, et al., 2005; Perminow et al., 2010; Ravikumara & 
Sandhu, 2006). However, the thought of a difference between developed and developing 
countries seems to be less than expected, based on results from recent studies (Bousvaros, et 
al., 2006; Ravikumara & Sandhu, 2006; Shikhare & Kugathasan, 2010). Conditions such as 
access to health care, genetic background, increased diagnostic accuracy due to advent of 
improved technology, increased awareness, and unavailable data due to limited reported 
cases, may be some of the reasons why differences occurs in different parts of the world 
(Baumgart & Carding, 2007; Ravikumara & Sandhu, 2006; Russel, 2000). In Norway, the 
total numbers of IBD patients are about 24,000. With a fairly realistic distribution, the 
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numbers of CD and UC cases are set to be 7,200 and 17,000, respectively. These numbers are 
based on statistic from Statistics Norway, and are a minimum number of cases. No separate 
statistics by age are worked out, but Statistics Norway is establishing an IBD registry in 
Norway that is handled by professional expertise, and a more complete list will be established 
during the upcoming years (Schatten, 2012). 
 
The onset of IBD can occur at any age (Biank, Broeckel, & Kugathasan, 2007; Bousvaros, et 
al., 2006; Khor, Gardet, & Xavier, 2011) but the peak of onset is in adolescent and present 
before the age of 20 years in 25 % of all IBD patients (Escher, et al., 2005; Shikhare & 
Kugathasan, 2010). It is therefor often conflicted with the pubertal growth and development, 
which does not make the disease easier to handle.  
 
3.2 Clinical presentation of pediatric IBD  !
To survey IBD from an early stage of the disease course can be an advantageous, to be able to 
start a treatment as soon as possible and further get control over the disease. Unfortunately in 
many pediatric (< 18 years) cases, the classical symptoms of IBD are absent and difficult to 
recognize and can in addition be reflected in a misinterpretation of pubertal development 
(Büller, 1997). UC and CD are different illnesses but are grouped together as IBD because 
they produce similar signs and symptoms (Shikhare & Kugathasan, 2010). In some situations 
there are difficult to see a clear distinction between the two diseases at their onset (Mikhailov 
& Furner, 2009; Ravikumara & Sandhu, 2006). 
 
Initial symptoms for children are often abdominal pain, loss of appetite, psychological stress, 
pubertal delay and impaired growth (Bousvaros, et al., 2006; Büller, 1997; Nieuwenhuis & 
Escher, 2008). Some of these circumstances can be present for a healthy, young person, e.g. 
the variation in growth velocity that is often considered to be part of ongoing puberty rather 
than a symptom of an ongoing disease (Büller, 1997). 36-88 % of children with IBD have 
impaired growth caused by multiple factors related to nutrition and the immune system, but 
the precise mechanisms by which they act are not fully understood (Bousvaros, et al., 2006).  
 
Ulcerative colitis is a relapsing disease and includes diffuse mucosal inflammation, extending 
from the rectum to the left or right colon (Figure 1) (Baumgart & Sandborn, 2007; Shikhare & 
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Kugathasan, 2010). Key features of UC include bloody diarrhea, abdominal pain, fever, and 
passage of pus and/or mucus (Sawczenko & Sandhu, 2003).  
 
Crohn’s disease is also a relapsing disease but can affect the entire gastrointestinal tract 
(Figure 1) from mouth to anus, normally patchy. Depending on the clinical presentation and 
disease location, patients with CD have diarrhea, abdominal pain, weight loss, fever, clinical 
signs of bowel obstruction, passage of blood and/or mucus, and persistent vomiting 
(Baumgart & Sandborn, 2007; Shikhare & Kugathasan, 2010). The three former symptoms 
are most common presenting of the disease but are not always presenting, and only 25 % of 
pediatric CD presents with the classic triad (Nieuwenhuis & Escher, 2008; Sawczenko & 
Sandhu, 2003). Relapse may be infrequent and occur once during one year but relapse can 
also be continuous with persistent symptoms without a period of remission (Stange et al., 
2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is important to note that there exists no hard scientific evidence about the differing etiology 
from child to adult but pediatric onsets differ from adult in many aspects. However, it is 
thought that the early onset of the disease represents a more aggressive phenotype than similar 
diseases in individuals older than 20 years (Biank, et al., 2007; Perminow, Reikvam, et al., 
2009). Whether the disease phenotype is a result from the difference in investigation for 
diagnose or represents a true phenotype difference, is uncertain (Biank, et al., 2007).  
Figure 1: Illustration of the gastrointestinal tract 
("progressivehealth," 2012). UC occurs from rectum to 
the left or right colon. CD can affect the entire 
gastrointestinal tract from mouth to anus. 
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3.3 Development of Inflammatory Bowel Disease !
Inflammatory bowel disease is of unidentified origin, but different environmental factors and 
the intestinal flora can initiate immunological mechanisms in genetically predisposed 
individuals and cause IBD (Figure 2) (Baumgart & Carding, 2007; Mikhailov & Furner, 
2009; Russel, 2000). 
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3.3.1 Environmental factors  !
Incidence of IBD has increased over the past decades (Ravikumara & Sandhu, 2006; Russel, 
2000) and especially among children (Escher, et al., 2005; Mikhailov & Furner, 2009). Rapid 
changes in the incidence can best be explained by changes in environmental factors since 
changes in genetic factors do not occur as rapidly as the incidence of IBD has been noted 
(Koloski, Bret, & Radford-Smith, 2008; Mikhailov & Furner, 2009; Russel, 2000). There 
have been reported several studies where connection between environmental factors and IBD 
was questioned. Breastfeeding, passive smoking, nutrition, and birth weight are some of the 
investigated areas (Mikhailov & Furner, 2009), but due to conflicting results, nothing can be 
stated yet (Koloski, et al., 2008; Mikhailov & Furner, 2009). Hygiene hypothesis have been 
posted as an explanation for the high frequency of IBD during the last decades where the 
hygiene has been improved. The thought of a child’s overprotection from exposure of 
common infections agents, and thereby omit developing of the immune system to later 
exposed infectious, may be a factor contributing to the pathogenesis of IBD. More 
Figure 2: Interacting factors contributing to IBD 
are intestinal flora, environmental triggers and 
the immune system in genetically predisposed 
individuals (Sartor, 2006). 
! *!!!
investigation to verify the hygiene hypothesis is needed (Koloski, et al., 2008; Sartor, 2008; 
Shikhare & Kugathasan, 2010). 
 
3.3.2 Genetic factors !
Genetic influence is considered to be an element for both UC and CD but is regarded to be 
strongest for CD (Baumgart & Carding, 2007; Joossens, et al., 2011; Mikhailov & Furner, 
2009). Based on the relatively short exposure time to environmental factors concerning 
children, is genetic influence thought to play a larger role for how the onset of the disease 
occur. Numerous family and twin studies and the discovery of many susceptibility genes 
strongly support the concept that IBD is highly heritable (Baumgart & Carding, 2007; Biank, 
et al., 2007; Escher, et al., 2005; Khor, et al., 2011; Shikhare & Kugathasan, 2010). However, 
as previously mentioned, genetic influence seems most likely not to be the strongest 
explanation for incidence of IBD because of the rapid changes during the last decades 
(Koloski, et al., 2008; Mikhailov & Furner, 2009; Russel, 2000). The first gene identified in 
CD is the NOD2/CARD15 gene that plays a role in bacterial sensing and defense against 
organisms (Joossens, et al., 2011). There have been found strong associations for mutation of 
NOD2/CARD15 gene, but is neither sufficient nor necessary for developing the disease, and 
up to 70 % of CD patients do not carry a NOD2/CARD15 mutation (Biank, et al., 2007).  
 
3.3.3 Immunobiology !
It is believed that inflammatory events originate from an abnormal activation of the mucosal 
immune system and a defect immune response (Khor, et al., 2011). The first line defense 
mechanism of the mucosal immune system is the epithelial barrier where the intestinal 
epithelium is a single layer covered by mucus in which commensal microbes are embedded. 
People suffering from IBD have their epithelial barrier and antigen recognition disturbed, and 
causes lowered epithelial resistance (Baumgart & Carding, 2007). Whether IBD is induced by 
a pathogen – a transient infection trigger what initiate IBD and then perpetuated in susceptible 
hosts by resident (not pathogenic) commensal luminal bacteria, or by an abnormal immune 
response to normal enteric microflora, are still unresolved questions (Sartor, 1997). It has also 
been few studies dealing with the immunology of pediatric IBD and as a result, survey of the 
early stages of the development of IBD has been missing (Bousvaros, et al., 2006).  
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3.3.4 Pathogenesis !
The pathogenesis of IBD remains poorly understood (Schwiertz, et al., 2010; Shikhare & 
Kugathasan, 2010), and to date, no specific microorganism is being directly associated with 
the pathogenesis (Marteau et al., 2004). In the course of time, there have been several bacteria 
identified among the pediatric IBD as an own distinct group. Bifidobacterium cell counts 
lower number in patients with active IBD compared with healthy controls (Schwiertz, et al., 
2010), and decreased number of Faecalibacterium prausnitzii, a predominant species of the 
Clostridia cluster IV, is characterized by CD pediatric (Joossens, et al., 2011; Schwiertz, et 
al., 2010). An increased number of E. coli has been reported in pediatric IBD and especially 
for CD (Cucchiara, et al., 2009; Schwiertz, et al., 2010). There must be noted that most light 
has been shed on the pathogenesis role for CD and most bacteria are reported from this 
disease (Joossens, et al., 2011; Mondot et al., 2011; Schwiertz, et al., 2010). 
 
3.4 Diagnostic procedures !
Disease activity and propagation is essential for therapy selection. The main goal is to get 
control over the inflammatory process and for the long-term; prevent relapses, limit disease 
complication, and improve quality of life for the patient (Baumgart & Sandborn, 2007; 
Shikhare & Kugathasan, 2010). An IBD diagnose is based on clinical signs and symptoms, 
laboratory manifestations, radiographic, endoscopic, and histological studies (Baumgart & 
Sandborn, 2007; Escher, et al., 2005; Mikhailov & Furner, 2009) and is a comprehensive 
process. The period to a diagnosis is confirmed is often conflicted with time and can be a 
demanding process for the patient, and early investigation in suspected cases can reduce 
delays (Sawczenko & Sandhu, 2003). 
 
During the 1960’s and 70’s, the endoscopic investigation was introduced for investigations in 
the gastrointestinal tract to be able to reveal cases of IBD. Eventually, methods were further 
developed and from the late 1980’s and the early 1990’s total colonoscopy was performed for 
IBD patients. For the pediatric population, the investigations were normally performed under 
general anesthesia up to the age of 16 but a strong indication for the disease had to be present. 
In later years, magnetic resonance imaging (MRI) was suggested in order to determine the 
extent of disease with a good accuracy (Perminow, 2010).  
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Mucosal biopsies from different segment of the colon and the ileum are normally 
accomplished to influence the accuracy of the histological diagnosis, and are collected during 
upper and lower endoscopy. Analyses of a full colonoscopic biopsy are performed for the 
initial diagnosis and further to confirm the diagnosis. Blood tests are investigated for a full 
blood count in patients with CD. The C-reactive protein is an indication of the acute phase 
response to inflammation and is correlated with disease activity (Stange, et al., 2006). 
 
4 TECHNIQUES FOR EXPLORING GUT MICROBIOTA  
The human gastrointestinal (GI) tract microbiota is vital for human health and is also 
implicated in several GI disorders (Qin, et al., 2010). Investigation and more attention are 
therefor important and several techniques have been used to explore the diversity in the 
bacterial community. This can lead to the discovery of biomarkers to understand and predict 
the microbial life in the human GI tract (Zoetendal, et al., 2008). Despite several 
breakthroughs on the composition and functionality, no information has yet been transformed 
into diagnostic procedures to reveal different diseases. The largest challenge in the gut 
microbiota diagnostics is the establishment of a correlation between microbiota patterns and 
disease. There are not many diseases that have been characterized with respect to specific 
dysbiosis of the microbiota, and this can be a challenge since a survey of the gut microbiota 
needs to further be explored to get more knowledge over the gut microbiota (Rudi & Isaksen, 
2012).  
 
4.1 Cultivation analysis !
The gut microbiota is a complex system and requires technology that can handle and construe 
the content. Traditional cultivation based analysis cannot be used to reveal signatures for the 
gut microbiota because most of the growth conditions for gut bacteria are unknown (Rudi & 
Isaksen, 2012). The myriad of bacteria in the human gut makes cultivation analysis not so 
relevant because the analysis comes to brevity. A challenge is also related to growth 
conditions since many of the bacteria in the human gut are strictly anaerobic. Many GI tract 
microbes also develops intimate relation with the host and with each other, which makes 
microbes dependent of the metabolic activity of another member of the ecosystem. Based on 
important features that is essential for the gut microbes can it be almost impossible to perform 
cultivation analysis (Zoetendal, et al., 2008).   
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4.2 High-throughput sequencing  !
High-throughput sequencing is a synonymous term with next-generation sequencing. Next-
generation sequencing can be used to open entirely new areas of biological inquiry and 
characterization of ecological diversity, which can be useful to get more understanding over 
the gut microbiota. The technology allows thousands of sequence reactions to performed in 
parallel. Primers are covalently attached to the template on solid surface through 
hybridization, and further DNA polymerase is bounded to the primer template configuration 
to initiate the next-generation sequencing reaction. DNA polymerase adds fluorescently 
modified nucleotides, which represent the complement of the template base, and can further 
be detected (Metzker, 2010). The major challenge by unprecedented amount of sequencing is 
the methods for data storages, transfer, and data analysis (Xiong, Zhao, Arnold, & Yu, 2010). 
It is also expected to take time and further development before sequencing of the gut 
microbiota can become a routine diagnostic tool (Rudi & Isaksen, 2012). 
 
4.3 DNA microarray !
The most commonly used high-throughput analytical method for the GI tract is DNA 
microarray (Zoetendal, et al., 2008). Microarray is an effectively powerful tool for its 
application for the analysis of intestinal samples, to provide novel insights into the 
relationship between microbiota in the human gut. Microarray encompassing over thousands 
of known sequences immobilized on a microscope slide and can further be subjected to a 
series of hybridization experiments that are performed simultaneously. The slide is hybridized 
with different labeled fluorescent probes and allows indication whether a particular gene is 
significantly expressed (Watson et al., 2008). This technology can target genes to measure 
abundance and diversity of the intestinal microbiota and to further reveal some signatures.  
 
Phylogenetic microarrays is used for characterization of GI tract microbiota to gain insight 
into the structure and population (Zoetendal, et al., 2008). Phylogenetic microarrays contain 
probes derived from rRNA sequence information and are suited for analysis of the microbial 
community, as GI tract. The oligonucleotide probes can be designed in a phylogenetic 
framework to survey different levels of sequences from broad taxonomic level to grouping at 
genus and species level. One critical issue by the use of microarrays is detection specificity, 
because rRNA genes are highly conserved and present in all microorganisms (Zhou, 2003). 
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Another limitation by the use of phylogenetic microarrays is the dependency on the isolation 
of nucleic acids and subsequent polymerase chain reaction (PCR) amplification of the gene. 
However, this is generally a drawback of culture-independent technologies. Phylogenetic 
microarrays have a dynamic range that only covers the dominant microbes present in the GI 
tract, and can be another limitation by the use of this analysis (Zoetendal, et al., 2008).  
 
4.4 Probe target 16S rRNA !
The most widely applied targeted approach to describe the human gut microbiota is the use of 
probes targeting 16S rRNA gene (Rudi & Isaksen, 2012). A probe is a short (about 14-25 bp) 
unlabeled oligonucleotide that is labeled if the target bacterium (the probe identifies) is 
present in a reaction (Vebø et al., 2011). One important feature for 16S rRNA gene is that this 
gene is present in all bacteria and can be used as a universal target for bacterial identification. 
Throughout evolution, small changes have been seen for 16S rRNA gene and the gene is also 
large enough (1,500 bp) to contain statistically relevant sequence information (Patel, 2001).  
 
4.5 SNuPE probe !
For a more direct approach to get a signature of the gut microbiota is the use of highly 
specific single nucleotide primer extension (SNuPE) probes. The SNuPE probes are 
constructed so that the probes hybridize adjacent to discriminative gene positions (16S rRNA 
gene) and is labeled with fluorescence by a DNA polymerase if the target bacterium is present 
(Vebø, et al., 2011). Genetic Analysis AS (GA) is a Norwegian company commercialized 
GA-mapTM (Genetic Analysis microbiota array platform) array technology within the field of 
molecular diagnostics of diseases related to gut imbalances ("Genetic Analysis," 2012). GA-
mapTM assay technology is based on use of highly specific SNuPE probes for target/non-target 
discrimination (Vebø, et al., 2011). Moreover, it can be performed on feces samples to get a 
profile over the patient’s gut, which can be related to various health conditions and diseases.  
 
4.6 GA-mapTM assay !
Genetic Analysis holds two GA-mapTM assays that are not currently commercially available 
on the market. The first is GA-mapTM Core assay and is based and constructed on probes 
established from microbial genomes that are shared from a healthy gut based on a study 
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performed in Europe. One hundred and twenty four individuals were collected in the study to 
determine a healthy microbial core to get a better understanding over the common microbes 
that have a profound influence on human physiology and are crucial for human life (Qin, et 
al., 2010). The second is GA-mapTM Infant assay and is designed to compare the temporal 
development of the gut microbiota in IgE-sensitized and non-sensitized children during the 
first two years of life. The assay represents the minimum number of probes that covers the 
expected diversity of bacteria in the infant gut (Vebø, et al., 2011).  
 
GA first started to perform analyzes on an array but has until recently switched to the use of 
assay with beads. The reason for the change was due to a time consuming process and less 
control of the samples, since the array was ordered and not produced by GA self. With current 
technology and the use of assay and beads, it is more likely that the SNuPE probe will capture 
the 16S rRNA in a reaction, instead of an immobilized probe on an array where the target-
bacterium had to catch one spot (Sekelja, 2012). 
 
5 THE 16S rRNA GENE AS A PHYLOGENETIC MARKER  
16S rRNA gene is present in all bacteria and can be used as a universal target for bacterial 
identification (Patel, 2001). 16S rRNA gene comprises of highly conserved regions and other 
hyper-variable regions. The conserved regions are important for classification of higher taxa, 
while the hyper-variable regions can be used for differentiation between closely related 
species (Rudi, Zimonja, Trosvik, & Næs, 2007). 
 
Species that share a common ancestor should be classified closer together than distantly 
related species (Fletcher, Hickey, & Winter, 2007) in an evolutionary connection. What is 
inferred from sequence data is an estimate of the phylogeny of a given gene but even without 
systematic errors there is intrinsic random errors in every phylogenetic tree. The best 
phylogenetic tree for a given molecule is not necessarily the correct phylogenetic tree for 
either the gene or the organism since the result is an inevitable consequence of the finite body 
of data used in the inference (Olsen & Woese, 1993). 
 
The gut microbiome is extremely complicated (Bousvaros, et al., 2006) and classification and 
phylogenetic studies can both be incorrect and hard to perform. Functionality of bacteria in 
the gut correlated to phylogeny is still an ongoing issue. Much point in the direction that 
! %&!!
functions cannot directly be inferred from the gut microbiota 16S rRNA gene analyses. 
However, phylogenetic framework can be used to deduce the probability of functions and 
establish correlations in the gut microbiota (Rudi & Isaksen, 2012).  
 
6 LUMINEX 
The company behind Luminex develops, manufactures and markets biological testing 
technologies with applications throughout the clinical diagnostic and life science industries. 
To be able to conduct biological tests (bioassays), the company uses technologies such as 
xMAP! and xTAG! ("Multiplexed Solutions for Life - Luminex Corporation," 2012). The 
original instruments behind xMAP technology are Luminex! 100/200TM and FLEXMAP 
3D! hardware, based on the principle of flow cytometry, laser and Photo Multiplying Tubes.  
 
MAGPIX! is a more recently introduced instrument and is based on fluorescent images 
where LED (light emitting diodes) and CCD (charge coupled device) camera analyses the 
samples. MAGPIX performs assays by photograph MagPlex microspheres (beads) and 
distinguishes 1 to 50 unique magnetic microspheres in a single sample. Microspheres is 
impregnated with dye mixture of red to infrared which makes it possible to identify each 
microsphere particle ("Multiplexed Solutions for Life - Luminex Corporation," 2012).  
 
7 MATERIALS AND METHODS 
7.1 Outline of the materials and methods used in this thesis 
 
This thesis was worked out as collaboration between Norwegian University of Life Sciences 
and Genetic Analysis AS (GA) and started in September 2011. GA has established a 
collaboration with Akershus University Hospital (Ahus), which has given GA access to 
unique feces material of people with IBD and non-IBD. A flow chart (Figure 3) is presented 
for a better understanding of the process through the present study. The first step was to 
develop GA-mapTM IBD assay, which included design of probes. Through second step, the 
patient samples were tested on three different diagnostic tools before they were analyzed on 
Magpix instrument. 
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Figure 3: Flow chart over materials 
and methods through the present work. 
Started with potential biological 
markers used as a base for developing 
probes, to be incorporated in GA-
mapTM IBD assay. Probes were 
designed with TNTProbeTool and 
tested at capillary gel electrophoresis 
and detected by TAMRA fluorescence. 
Diagnostic tools (Core, Infant and IBD) 
were used at Magpix together with 
cohort samples, to detect (by SAPE 
fluorescence) bacteria from IBD and 
non-IBD. Purple line presents 
development of GA-mapTM IBD assay 
and blue line presents analysis of 
patient samples. Dashed lines indicated 
steps performed by GA and Ahus.  
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7.2 Development of GA-mapTM IBD assay 
 
7.2.1 Identify gastro intestinal bacteria suitable for IBD diagnostics !
Prior to this thesis there have been performed literature research by Genetic Analysis to 
identify gastro intestinal bacteria suitable for inflammatory bowel disease (IBD) diagnostics. 
By classifying amounts of bacteria from fecal and mucosa as increased, equal or decreased 
relative to controls (Frøyland, 2010) there was accomplished a list with 157 genus and species 
names to be included for GA-mapTM IBD diagnostic. This list was the basis for the probe 
search performed in present work.  
 
7.2.2 Design of probe in TNTProbeTool !
TNTProbeTool version 1.0 software program (made by GA) was used for design of a probe 
sequence. The names of different species and genus bacteria found through literature research 
were the basis for the probe search. The user defined target bacterium among target group and 
resulted all other bacteria to be non-target. TNTProbeTool used 8-nucleotide as the length of 
matching area for probe search. This implied a start criterion for areas at target sequence and 
was not found among non-target bacteria. The matching area was the base for the probe but 
the 8-nucleotide area was extended to fulfill demanded melting temperature (Tm) before a 
final probe suggestion could be designed. The definition of Tm is the temperature (°C) at 
which 50 % of the oligonucleotide and its perfect complement is in duplex 
("www.sigmaaldrich.com," 1998). The Tm was essential for probe design to succeed a good 
hybridization and several factors were included, for instance “nearest-neighbor” (Sekelja, 
2012). More information behind TNTProbeTool is noted in Appendix C.  
 
Probes were designed in TNTProbeTool with a minimum Tm of 55 °C by the nearest neighbor 
for the target group, and Tm  < 30°C or absence of a cytosine for non-target group. After a 
probe was designed, it was tested for duplication (performed by GA). A duplicated probe is 
the existence of a copy that already is presented in GA library. Duplicated probes will not be 
deleted from the study but will be assigned the originally probe identification from the 
existing probe. Oligonucleotides (probe material) were ordered through Thermo Scientific, 
Germany. Arrived probes from Thermo Scientific were stored at 4 °C before they were 
diluted to 100 pmol/µl (stock sample) and 1 µM (working solution) and later stored at "20 °C. 
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7.2.3 Preparation of template !
Isolated DNA was amplified by CoverAllTM primer and ExoSAP-treated. DNA quantification 
was performed with Gel Electrophoresis and PicoGreen.  
 
7.2.3.1 16S rRNA amplification by the CoverAllTM primer !
All bacterial 16S rRNA gene contains conserved region on the 5’ and 3’ ends. The 
CoverAllTM takes advantages of the two flanking conserved regions by using primers 
(forward and reverse) that anneal to this area of the DNA. 16S rRNA gene amplification by 
the CoverAllTM primer was performed as follows: 0.05 U HOT FIREPol! DNA Polymerase 
(Solis Biodyne), 1 x HOT FIREPol! buffer2 (Solis Biodyne), 2.5 mM Magnesium-dichloride 
(Solis Biodyne), 200 µM deoxynucleotide triphosphate (dNTP) (Applied Biosystems), 0.2 
µM Mangala forward primer (Genetic Analysis), 0.2 µM 16S 1015U reverse primer (Genetic 
Analysis) and 5-100 ng bacterium template in a total reaction volume of 50 µl. 0.2 µM 
positive (E. coli) and negative controls (no template) were added. The amplification by the 
CoverAllTM primers included a 15 min initial denaturation stage at 95 °C, followed by 30 
cycles with 30 sec denaturation at 95 °C, 30 sec annealing at 55 °C, and 80 sec elongation at 
72 °C. The final elongation was performed at 72 °C in 7 min. Amplification by CoverAllTM 
primer was accomplished on Veriti 96 well Thermal Cycler (Applied Biosystems) (Nestestog, 
2010a).  
 
7.2.3.2 Gel Electrophoresis  !
Gel electrophoresis was used to visualize amplificated PCR product of bacterial 16S rRNA 
gene. Gel electrophoresis DNA quantification was performed as follows: 1.5% agarose 
powder (SERVA), Red Gel Nucleic Acid Strain (BIOTIUM), 1X TBE buffer, 6X Gel 
Loading Dye (New England BioLabs), 1-Kb DNA Ladder (New England Biolabs) and 
amplified 16S rRNA gene product. Positive and negative controls were added. Run gel: 100 
V, 50 mA, in 40 min and visualized band by UV light used INGENIUS (SYNGENE BIO 
IMAGING) and GeneSnap Gel Analysis Software (SYNGENE) for image (Nestestog, 
2010b). Results from gel electrophoresis are not shown in this thesis. 
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7.2.3.3 PicoGreen  !
PicoGreen was used for detection and quantitate amounts of DNA (in ng/µl). Quant-iTTM 
PicoGreen dsDNA reagent is an ultrasensitive fluorescent nucleic acid strain for quantitating 
double-stranded DNA (dsDNA). Concentration was measured with absorbance at 260 nm 
(A260). PicoGreen DNA quantification was performed as follows: Quant-iTTM PicoGreen 
dsDNA (InvitrogenTM), 20X TE buffer (InvitrogenTM), Lambda DNA Standard (InvitrogenTM) 
and amplified 16S rRNA gene product. Non-amplified master mix (NAMM) (Genetic 
Analysis) was included to serve as a control for PicoGreen measurement. Lambda was used 
for DNA standard curve where fluorescence intensity vs. DNA concentration was plotted so 
quantitative amount of DNA in samples could be measured. PicoGreen was performed with 
FLUOstar OPTIMA (BMG LABTECH) and OPTIMA software version 2.20R2 (BMG 
LABTECH) (Nestestog, 2010c). Referred to Invitrogen protocol for more detailed 
information behind PicoGreen (Invitrogen, 2008). Results from PicoGreen measurements are 
not shown in this thesis. 
 
7.2.3.4 Exonuclease I (Exo I) and Shrimp Alkaline Phosphatase (SAP) –treatment  !
Exo I removed nucleotides from single-stranded DNA in 3’ to 5’ direction from a reaction 
mixture after PCR. SAP removed phosphate groups from the 5’ end of DNA and hence 
dephosphorylated excess deoxynucleotide triphosphates (dNTP) remaining after PCR. PCR 
product was ExoSAP-treated with 3 U Exonuclease I (BioLabs#) and 8 U Shrimp Alkaline 
Phosphatase (ArcticZymes). The treatment included a 120 min enzyme activation step at 37 
°C before 15 min inactivation step at 80 °C and was performed on Veriti 96 well Thermal 
Cycler (Applied Biosystems) (Kreso, 2010). 
 
7.2.4 Probe analysis on capillary gel electrophoresis !
DNA hybridize by forming hydrogen bonds between its nucleotides: Adenine (A) forms two 
hydrogen bonds with thymine (T), and guanine (G) forms three hydrogen bonds with cytosine 
(C) (Vebø, et al., 2011). A probe hybridized adjacent to discriminative gene position and was 
incorporated with fluorescence by DNA polymerase if the bacterium was presented (Vebø, et 
al., 2011). Labeling occurred at 3‘ end of the probe after the whole probe had hybridized to 
bacterium template.  
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Two hundred and seventeen probes were tested to identify probes that satisfied criteria of 
target detection and non-target exclusion. This was performed through end-labeling for each 
single probe in following order: self-hybridization (I), target bacteria (II), up to 10 non-target 
bacteria (III) and probe used in probe set (IV). To test a probe against target and non-target –
bacteria there was used bacterial DNA from pure culture (template) as described in section 
7.2.3. Template was replaced with water during self-hybridization (I) and probe tested in a 
probe set (IV).  
 
7.2.4.1 End-labeling reaction !
End-labeling reaction was as follows: 0.25 U HOT Termipol DNA polymerase (Solis 
Biodyne), 1 x HOT Termipol buffer C polymerase (Solis Biodyne), 4 mM Magnesium-
dichloride (Solis Biodyne), 0.4 µM ddCTP-TAMRA (5-propargylamino-ddCTP – 5/6- 
TAMRA) (Jena Bioscienc), 0.1 µM probe and 5-100 ng/ml bacterium template in a total 
reaction volume of 10 µl. The end-labeling included a 12 min initial denaturation stage at 95 
°C, followed by 10 cycles with 20 sec denaturation at 96 °C, 30 sec annealing at 60 °C, and 5 
sec extension at 60 °C. Positive control was included with probe (Universal 4) and E. coli as 
template. Negative control included end-labeling reagents without probe or template (replaced 
with water). End-labeling was performed on Veriti 96 well Thermal Cycler (Applied 
Biosystems) (Frøyland, 2011b).  
 
7.2.4.2 Shrimp Alkaline Phosphatase (SAP)-treatment  !
SAP-treatment was performed to remove phosphate groups from the 5’ end of DNA. TAMRA 
labeled product was treated with 0.09 U SAP (ArcticZymes) in a total reaction volume of 11 
µl, and incubated at 37 °C for 60 min and inactivated at 80 °C for 15 min on Veriti 96 well 
Thermal Cycler (Applied Biosystems) (Frøyland, 2011b).  
 
7.2.4.3 Preparation for Genetic Analyzer  
 
SAP-treated and end-labeled product was handled with Hi-DiTM Formamid (Applied 
Biosystems) and GenScan 120 LIZ Size Standard (Applied Biosystems) in a total reaction 
volume of 10.5 µl and incubated at 95 °C for 5 min on Veriti 96 well Thermal Cycler 
(Applied Biosystems) (Frøyland, 2011b). This step was performed for preparation for the 
! %,!!
Genetic Analyser (capillary gel electrophoresis) where Hi-DiTM Formamid kept template and 
probe denatured through the analyses, and GenScan 120 LIZ Size Standard was present for 
size standard and presented different fragments in GeneMapper (software program for 
analyzing results from Genetic Analyser). 
 
7.2.4.4 Testing probes on capillary gel electrophoresis !
All probes were evaluated by using ABI Genetic Analyzer 3130xl sequencer (Applied 
Biosystems) and analyzed with the software program GeneMapper version 4.0 (Applied 
Biosystems). Probe tested for target detection was required signal up to 7,000 – 8,000. 
Concerning self-hybridization and probes tested for non-target detection, no signals were 
desired (see Appendix D for examples over how results could be seen). Self-hybridization 
probes were excluded by signals over 150. For target detection, probes were excluded if they 
got signals under 500 or double peaks. According to non-target detection, probes were 
excluded with signals over 300 or double peaks. An optimal probe gave signals over 1,000 
and under 160 for target detection and non-target detection, respectively.  
 
7.2.5 The election process of probes to GA-mapTM IBD assay !
A probe set (GA-mapTM IBD assay) could hold 50 probes/bacteria (included control). An 
election process was therefor important for decision of which probes that should be included 
in the probe set. The election process was determined on the basis of five criteria. The first 
criterion was to choose optimal probes. An optimal probe does not self-hybridize nor captures 
non-target bacteria. An optimal probe was a specific probe that only captured the target 
bacterium (I). The next criterion was frequently reported bacteria. Even though all bacteria 
related to the intestinal microbiota according to IBD was of interest, there are some bacteria 
that have been more frequently reported and seems more important than others (II). In 
addition to the frequently reported, bacteria related to Crohn’s disease are of more interest 
compared to ulcerative colitis. This is due to the fact that there are found less correlation 
between bacteria and ulcerative colitis (III). A probe must work with other probes (not 
hybridize) in a probe set. This was performed in TNTProbeTool (by GA) where all probe 
sequences were tested against each other (IV). A probe set should include at least one 
bacterium per phylum (Firmicutes, Actinobacteria, Bacteroides and Proteobacteria) related to 
the intestinal tract (V). 
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7.3 Analysis of patient samples !
7.3.1 Cohort  !
Akershus University Hospital (Ahus) holds feces samples from people suffering from IBD 
before they have gone through medication and treatments. Feces samples were from a large 
population-based study in Norway focused on inflammatory bowel disease at all ages, and 
named Inflammatory Bowel South Eastern Norway – II (IBSEN-II). A diagnose was set 
according to Porto criteria (Appendix A) and based on histopathological verification in 
biopsis taken during upper and lower endoscopy. Endoscopic procedure in children (<16 
years) was performed under general anesthesia (Perminow, Brackmann, et al., 2009), and 
stool samples were collected for microbiological investigations to exclude infectious causes, 
e.g. Salmonella, Shigella, Yersinia and Campylobacter (Escher, et al., 2005). 
 
Seventy-four 74 feces samples, represented from the pediatric part of IBSEN-II study, and 
included 28 CD samples, 15 UC samples, 3 IBDU samples (unconfirmed prognosis), and 28 
non-IBD samples (Appendix H). The samples were randomly distributed on three plates (due 
to other adults samples from IBSEN-II, not included in this thesis). !
7.3.2 Preparation of template !
Ahus isolated DNA from feces samples. DNA was amplified by CoverAllTM primer, DNA 
quantificated, and ExoSAP-treated as described in section 7.2.3.  !
7.3.3 Analysis on MagpixTM instrument  !
Cohort (IBSEN-II samples) was first analyzed with two diagnostic probe sets: GA-mapTM 
Core assay (probes included are noted in Appendix L) and GA-mapTM Infant assay (probes 
included are noted in Appendix M). The two diagnostic tools were together with GA-mapTM 
IBD assay analyzed in a second round.  
 
The first step for analyzing samples on Magpix instrument was end-labeling. During end-
labeling was labeling probes tested against cohort samples and the probes were labeled if the 
bacterium the probe identified was present. The next step was hybridization between labeling 
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probe and capture probe (complementary sequence for labeling probe). Capture probe was 
coupled to microspheres (beads) and detected by Magpix instrument in the third step.   
 
7.3.3.1 End-labeling of labeling probes !
End-labeling reaction of probes for the Magpix platform was as follows: 0.125 U HOT 
Termipol DNA polymerase (Solis Biodyne), 1 X Buffer C (Solis Biodyne), 4 mM 
Magnesium-dichloride (Solis Biodyne), 0.5 µM Biotin-11-ddCTP (PerkinElmerTM Precisely), 
0.01 µM probe and ExoSAP-treated PCR-products (IBSEN-II samples) in at total reaction 
volume of 10 µl. End labeling included a 12 min initial denaturation stage at 95 °C, followed 
by 5 cycles with 20 sec denaturation at 96 °C, and 35 sec combined annealing, and elongation 
at 60 °C performed on Veriti 96 well Thermal Cycler (Applied Biosystems) (Vebø, 2012).!
 
7.3.3.2 Capture probes analyzed on MagpixTM !
MagPlex microsphere (bead) was 6,2 microns in diameter, contained surface carboxyl groups, 
and superparamagnetic. Microsphere was internally labeled with fluorescent dye, and one 
specific dye per microspheres gave specific recognition and separation. The microsphere was 
coupled with capture probes (complementary sequence of labeling probe) to be able to 
capture a labeling probe that was labeled with fluorescent if the target bacterium was present 
from cohort sample. Capture probe was tagged with a 5’ end amino modified C12 – a reactive 
primary amino group and facilitated the coupling to the carboxyl group on the microspheres 
(Frøyland, 2011a). Illustration for how labeling probe hybridized to cohort samples, and 
further was captured by capture probe, before the capture probe was detected by fluorescent at 
Magpix instrument, can be seen in figure 4.  
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3. Labeled probe and 
target bacterium 
denatured at 95 °C. 
\!
6. Labeled with fluorescent and ready for detection 
at Magpix instrument.  
1. Target bacterium (isolated from cohort 
sample) and labeling probes in a solution.  
2. Labeling probe hybridize to discriminative 
gene position at target bacterium before 
ddCTP-biotine was incorporated.  
4. Microsphere and capture probe coupled  
5. Capture probe coupled to microsphere, 
labeled probe, and fluorescent (streptavidin- 
R-phycoerythrin) in a solution.!
Figure 4: Labeling probe hybridizes to target bacterium (template) and is incorporated with ddCTP-
biotine. Biotin-labeled probe and template is denatured before biotin-labeled probe hybridizes to capture 
probe (complementary sequence to labeling probe). To be detected by Magpix instrument, streptavidin 
binds to ddCTP-biotine before labeled with phycoerythrin. Phycoerythrin was the fluorescence and was a 
component of the complex streptavidin-R-phycoerythrin (Vebø, 2012). 
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One capture probe was coupled to one microsphere (performed by GA). A selected 
oligonucleotide-coupled microsphere set was vortexed and sonicated for 20 sec before the set 
was diluted around 1:20 in 1.5 X Tetramethylammonium chloride (TMAC) hybridization 
buffer (SIGMA Life Science). 1.5 X TMAC consisted of 4.5 M TMAC, 0.15 % Sarkosyl, 75 
mM Tris-HCl (pH 8.0), 6 mM EDTA (pH 8.0) and H2O. Sonication and vortexing were 
performed to prevent uncoupled microspheres to stick together and further to bring them in 
homogenized solution. A 1:4 ratio (labeled:unlabeled) mix of a hybridization control probe 
consisting of a pre-labeled (oligonucleotide probe modified with a 3’ ddCTP-biotin, 0.1 µM 
HYC01_Biotin) and the same oligonucleotide probe without 3’ ddCTP-biotin (0.1 µM 
HYC01) were added to each well. HYC01 was used to evaluate the hybridization step and to 
normalize differences in hybridization efficiencies. One well contained up to 50 different 
microspheres (coupled with capture probes), hybridization control, and end-labeled reaction 
and constituted a total reaction volume of 50 µl, before the hybridization was initiated. The 
hybridization included a 3 min denaturation stage at 95 °C for any secondary structure in the 
oligonucleotide probe, followed by 15 min hybridization of oligonucleotide probe to 
complementary capture probe at 45 °C performed on Veriti 96 well Thermal Cycler (Applied 
Biosystems) (Vebø, 2012). 
 
The hybridized samples were then added 0.03 µg Streptavidin-R-phycoerythrin (SAPE) 
(Invitrogen) and 1 X TMAC Hybridization Solution (consists of 3 M TMAC, 0.1 % Sarkosyl, 
50 mM Tris-HCl (pH 8.0), 4 mM EDTA (pH 8.0) and H2O) in a total reaction volume of 75 
µl (in each well), and the samples were incubated further at 45 °C for 15 min on Veriti 96 
well Thermal Cycler (Applied Biosystems) (Vebø, 2012). 
 
The samples were analyzed with Magpix instrument. In each well, totally 50 µl microspheres 
(mixture of the different microspheres) were absorbed and brought to a magnet that held the 
magnetic microspheres in place while the microspheres were illuminated and imaged by a red 
and green light-emitting diode (LED). The samples were first measured for internal dye 
fluorescence for classification and to distinguish the 50 different microspheres by the red 
LED, before the green LED excites surface and reports fluorescence (phycoerythrin). The 
magnetic microspheres were washed before illumination to reduce disturbance. At least 50 
microspheres needed to be counted from each type to get the measure approved. There is also 
an upper limit for the magnet to hold the microspheres before disturbance destroys the signal.  
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Analyzes of the images were performed by Luminex xPONENT software (Luminex, 2011).  
How the Magpix instrument is build up and how the samples are run at the instrument are 
denoted in Appendix B.  
 
7.4 Statistical analysis  
 
There were several steps in the statistical analysis before results over probes and samples 
could be announced, and the steps were: 
 
1. Pre-processing – reduce noise and irrelevant information. 
2. Make classifications – healthy vs. sick people using probe signals as predictors. 
3. Cross-validation – leave-one-out.  
4. Present the results. 
 
7.4.1 Multivariate statistic  !
When probes were tested against cohort, one was left with large amounts of data that included 
many variables. To find a connection between probes and samples, and to analyze more than 
two variables, multivariate data analysis was performed to represent a simplification of the 
data (Nortvedt, Brakstad, Kvalheim, & Lundstedt, 1996). The two multivariate data analyses 
used in the present work were Principal Component Analysis (PCA) and Partial Least Squares 
– Discriminant Analysis (PLS-DA).  
 
PCA describes the variation in a data matrix by finding new variables called super-variables 
that maximize the explained variance in the data. PCA can therefore be useful in the 
visualization of the most important information that can be extracted from a data set with 
many variables. PLS-DA is a classical regression that decomposes a data matrix in a similar 
way as the PCA but uses additional information (diagnostic information from each patient) to 
find super-variables. Super-variables were found by using information in one or more 
response variables, to control separation of the samples. Score plot and loading plot were used 
to present super-variable results where score presented cohort samples and loading presented 
probes (Sekelja, 2012). The principle behind PCA and PLS-DA is described in Appendix E. 
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7.4.2 Pre-processing !
Pre-processing was performed of raw data to reduce noise and irrelevant variation before the 
data was analyzed with respect to diagnosis. To reduce plate-to-plate variation, plate ID was 
used as response variable and probe signals as explanatory variable. Hybridization control 
probe (HYC01) was used to compensate for the time differences that occurred between the 
three plates, and all the signals from one well were divided at HYC01 signal. Raw data was 
sorted into score-plot and loading-plot. Score values presented IBSEN-II samples and their 
location in the new coordinate system, while the loading values presented probes that 
contributed to form the basis for the new coordinate system (Sekelja, 2012). Information 
behind pre-processing is described in Appendix F. 
 
7.4.3 Classification and discriminant analysis !
Classification was used to arrange predefined groups (IBD/non-IBD) and included sensitivity, 
specificity and classification error. The sensitivity explained the percentage of people 
classified as IBD, while specificity explained the percentage of people classified as non-IBD. 
Classification error (number between 0 and 1) described the amount of people misclassified, 
e.g. how many healthy people that were classified as sick (Sekelja, 2012). More information 
about classification can be seen in Appendix G. A discriminant analysis explained what 
distinguished different groups from each other by looking at the characteristics of groups (e.g. 
bacterial composition of the samples belonging to IBD/non-IBD group) (Sekelja, 2012). 
 
7.4.4 Cross-validation !
A cross-validation method called “leave-one-out” was used for the present work. The 
principle behind “leave one out” is simple; take one sample out at a time, and then build a 
classification model and compare the predicted value of the sample taken out with its 
observed value. The process is repeated until all the samples have been left out once (Browne, 
2000). The correlation between the predicted and the actually observed values can be used as 
a measure of the model’s usefulness and can give a value for how GA-mapTM assay 
corresponded to distinguish between IBD and non-IBD. 
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8 RESULTS 
 
8.1 Probe designed in TNTProbeTool !
Designed probes in TNTProbeTool are reported in Appendix I (species-probes) and Appendix 
J (genus/class/order-probes). Comments for the probe search are also noted in the mentioned 
appendices. Repeated problems during probe design were designated to no available bacteria, 
in addition to melting temperature (Tm). Total number of probes designed in TNTProbeTool 
is reported in table 1. 
 
8.2 Capillary gel electrophoresis !
Results from probes tested against target and non-target bacteria at capillary gel 
electrophoresis, are reported in Appendix K. Based on results from capillary gel 
electrophoresis, the probes were categorized and given color code, to be able to distinguish 
optimal probe and excluded probes. A summarized overview of number of probes tested on 
capillary gel electrophoresis is presented in table 1.   
 
Table 1: Summarized results over number of probes designed in TNTProbeTool and probes tested on capillary gel 
electrophoresis. Color code represents probe within the different categories.    
 Category  Number 
TNTProbeTool Probe designed with TNTProbeTool  471 
    
  Color code  
Capillary gel 
electrophoresis 
Tested at GA from earlier study (not tested at capillary)   22 
Excluded from study: self-hybrid., or unspecific probe   69 
Excluded from study: target bacterium not available   68 
Problem with signals at capillary   23 
Optimal probe   57 
Optimal species probe  53 
Optimal probe at higher taxonomic level  4 
Total number of probes tested on capillary  217 
 
 
Totally 471 probes were designed in TNTProbeTool and further were 217 probes tested on 
capillary gel electrophoresis, as seen in table 1. Results after the probes were tested on 
capillary gel electrophoresis excluded 69 probes due to self-hybridization or non-specificity. 
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Fifty-seven probes could be categorized as an optimal probe where 53 probes were designed 
at species level. Results from Appendix K showed double peaks that occurred for some of the 
probes as an indication for a non-optimal probe.  
 
8.3 GA-mapTM IBD assay  !
Probe identification with its target bacterium used in GA-mapTM IBD assay are presented in 
table 2. More comprehensive information concerning relatedness of bacteria is denoted in 
Appendix N.   
 
Table 2: Bacteria and probe ID incorporated in GA-mapTM IBD assay.  
Target bacteria Probe ID  
Akkermansia muciniphila AG0798 
Catenibacterium mitsuokai AG0894 
Clostridium aminophilum AG0899 
Clostridium difficile AG0907 
Clostridium methylpentosum AG0912 
Clostridium ramosum IG0013 
Dialister invisus AG0931 
Fusobacterium periodonticum IG0113 
Haemophilus (genus) AG1021 
Lactobacillus johnsonii AG1051 
Lactobacillus ruminis AG1058 
Pseudomonas straminea AG1133 
Ruminococcus albus AG1148 
Veillonella (genus) AG1207 
Bifidobacteria AG1219 
Alistipes putredinis AG0339 
Bacteroides fragilis AG0377 
Bacteroides stercoris AG0416 
Clostridium leptum        AG0470 
Coprococcus comes AG0495 
Coprococcus eutactus AG0569 
Dorea formicigenerans AG0581 
Enterococcus faecalis AG0591 
Eubacterium rectale       AG0620 
Faecalibacterium prausnitzii       AG0651 
Ruminococcus gnavus AG0703 
Subdoligranulum (genus) AG0744 
Bacillus licheniformis AG0849 
Bacteroides acidofaciens AG0861 
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Enterococcus faecium AG0962 
Eubacterium biforme AG0974 
Helicobacter canis AG1024 
Helicobacter hepaticus AG1030 
Klebsiella pneumoniae AG1033 
Lactobacillus reuteri AG1057 
Mannheimia (genus) AG1066 
Blautia schinkii AG1228 
Proteobacteria (phylum) IG0005 
Haemophilus parainfluenza IG0008 
Firmicutes 1  (phylum)   IG0012 
Firmicutes 2  (phylum) IG0023 
Gammaproteobacteria (class) IG0056 
Bacteroides (genus) IG0060 
E.coli/Shigella IG0133 
Blautia coccoides/Clostridium coccoides AG0879 
Roseburia hominis AG1146 
Ruminococcus bromii L263 AG1152 
Bifidobacteria IG0028 
Enterococcus (genus) IG0014 
Universal probe UNI05 
 
8.4 Partial Least Squares – Discriminant Analysis (PLS-DA) !
Through statistical analysis was there observed best correlation between CD and non-IBD, 
and best results were obtained from GA-mapTM Core assay and GA-mapTM Infant assay. 
Further results are based on the mentioned observations (Sekelja, 2012) and can be seen in 
analysis report (in section 8.4.2) 
 
8.4.1 Pre-processing !
Raw data is sorted into score and loading -plot in figure 5 as a result from plate variation. 
Score plot show cohort samples that are distributed among three plates. The two probe sets 
(core and infant) can be seen in loading plot. Score presents cohort samples and their location 
in the new coordinate system, while loading presents probes that contribute to form the basis 
for the new coordinate system. Loading and score plot can be compared to reveal which probe 
set that contributes to difference among the three plates. 
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Figure 5 presented the result of the raw data where a clear difference among the three plates 
could be seen. By comparing score and loading –plot horizontal, one could see that probes 
from core probe set (in loading plot) contributed to the difference for plate 3 (in score plot), 
while probes from infant contributed to the difference for plate 1.  
 
Small differences that occurred naturally between plates are to be reduced through pre-
processing. By using results from PLS-DA with plate ID as response variable and probe 
signals as explanatory variables, one can reduce plate-to-plate variation, as shown in figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Reveals different signal strength between the plates. Left: core set and infant set presented in loading plot. Right: 
three plates of cohort samples distributed in scores plot.  
            Core set                                Infant set                              Plate 1                Plate 2              Plate 3 
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As a result from reduced plate-to-plate variation in figure 6, the plates were less clustered and 
further more distributed along the x-axis. Differences among plates and probes could no 
longer be observed.  
 
8.4.2 Analysis report from PLS-DA !
Statistically work was performed in two separated parts where first the GA-mapTM Core assay 
(core) and GA-mapTM Infant assay (infant) were included, and secondly where GA-mapTM 
Core assay, GA-mapTM Infant and GA-mapTM IBD (IBD001) were included. All samples 
were analyzed with the whole cohort (CD, UC, IBDU and non-IBD) but during statistically 
work, there was found best correlation for CD and non-IBD (Sekelja, 2012). This can be seen 
in table 3 as a result from analysis report through cross-validation in PLS-DA. 
 
Table 3: Analysis report from PLS-DA over CD and non-IBD for core+ 
infant, and core+infant+IBD001. Specificity, sensitivity and accuracy  
(in percent) are shown for the two tests.  
 CD/non-IBD 
 Core + Infant Core + Infant + IBD001 
Specificity 82  61 
Sensitivity 86 46 
Accuracy 84 54 
 
            Core set                                Infant set                              Plate 1                Plate 2                 Plate 3 
Figure 6: Results after correction of variation. Left: core set and infant set represented in loading plot. Right: Three plates of 
cohort samples represented in scores plot.   
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Based on results from table 3, one could see that core+infant gave highest scores, which 
indicated best result. Specificity, sensitivity and accuracy for core+infant were 82 %, 86 % 
and 84 %, respectively. Accuracy for 84 % gave a classification error by 16 %.  
 
8.4.3 Score plot  !
Score plot over subject diagnosed with CD and subject classified as non-IBD for cohort 
samples and their location in the new coordinate system, are presented in figure 7. Samples 
vs. predicted subjects are presented in figure 8 where an indication for misclassified samples 
(results from cross-validated results) is shown with a cutoff for 0.5. CD samples are to be 
present over the cutoff value and non-IBD under the cutoff value.   
 
!
Figure 7: Subjects diagnosed with CD (red) and subject classified as non-IBD (green) presented in  
score plot.  
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Figure 8:  Predicted vs. samples over non-IBD (green) and CD (red). 9 of 56 were misclassified by  
the cutoff for 0.5. 
 
Figure 7 showed separation between CD and non-IBD and their location in the new 
coordinate system. The result from cross-validation was presented in figure 8 and displayed 9 
of 56 samples as misclassified by a cutoff for 0.5 as a result from non-IBD classified as IBD 
and IBD as non-IBD. 
 
8.4.4 Loading plot  !
In figure 9, the probes are presented in loading plot to see which probes that are contributing 
to distinguish non-IBD from CD. The same loading plot is presented in figure 10 but probe ID 
is replaced with name of the bacteria. Probes that stretch far out in loading plot contributes to 
most separation between CD and non-IBD. 
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!
                    Figure 9:"Loading plot for probe identification over probes that contributed to distinguish  
                    between CD (red circle) and non-IBD (green circle)."!!
 
 !
 
 
 
 
 
 
 !!!!!!!!!!!!!!!!!Figure 10: Loading plot over bacteria that contributed to distinguish between CD (red circle)  
                    and non-IBD (green circle).  
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As seen in figure 9 and 10 there were bacteria that contributed to distinguish between CD and 
non-IBD. Bacteria for non-IBD direction were: Eubacterium siraeum, Bacteroides sp. 2 2 4, 
Bacteroides fragilis, Bacteroides, IG0011 (Salmonella, Citrobacter, Cronobacter, 
Enterobacter and Morganelle), IG0081 (Streptococcus agalactiae and Eubacterium rectale). 
Bacteria directed for CD were: Collinsella aerofaciens, Finegoldia magna, Bacteroides 
intestinalis, Ruminococcus hansenii (Blautia hansenii), Subdoligranulum 
variable/Faecalibacterium prausnitzii, Clostridium butyricum, Alistipes putredinis, 
Ruminococcus torques and Bacteroides caccae. 
 
9 DISCUSSION 
 
9.1 Cohort samples 
 
Non-IBD was a systematic control group for patients not having IBD. Those people who were 
included as non-IBD came initially to the doctor because they had intestinal problems. By 
further testing, they passed not the Porto criteria and were therefor not considered as IBD 
patients. To what extend this affected and weakened the result between IBD and non-IBD was 
uncertain, and can only be confirmed by performing investigations with another control 
group. However, the gut is affected by microbial and host interactions and by external and 
internal factors (Cucchiara, et al., 2009; Fanaro, et al., 2003). People from control group will 
always have individual compounds of microbiota, and non-IBD can be suitable enough as 
control group.    
 
Material of detection in present work represented feces samples from cohort. In the literature 
there are many studies that collect samples from mucosal flora, to investigate the microbiota. 
Feces represents a sample from the bacterial community that reflects the bacteriology of the 
rectum, and do not offer much ecological knowledge of other regions of the GI tract. Mucosal 
biopsy provides samples, collected from regions of the intestinal tract where inflammation 
occurs (Tannock, 2008). It is conflicting evidence whether feces represents a sample 
correlated to the actually activity of the intestinal microbiota or not. Some believe that fecal 
flora is different from mucosal flora, and it is more important to study the latter because they 
appear to play a greater role in cases of IBD (Bousvaros, et al., 2006). In contrast, there have 
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been found high degree of similarity between bacterial collections associated with biopsy and 
feces (Bibiloni et al., 2008). 
 
There is without doubt a more comprehensive task to undergo a biopsy compared to give a 
feces sample. From a person’s point of view, a feces sample is more easily available and gives 
less discomfort compared to biopsy, which is important in terms of the person.  
 
9.2 Probe designed in TNTProbeTool !
In several cases one could not detect probes that satisfied the search criteria through 
TNTProbeTool. Problems by distinguish target bacterium from non-target bacteria could 
cause no probe design. Nearby non-target bacteria, surrounded target bacterium that disturbed 
the probe search, were deleted due to their sequence similarities. If many nearby non-target 
bacteria were deleted, the probe would be less specific. The meaning of a specific probe 
correlates to single annealing to the complementary sequence present on only target 
bacterium. An unspecific probe could capture more than the target bacterium and causing 
unwanted bacteria to be caught.  
 
The melting temperature (Tm) was set to be 60 °C under normal conditions when probe search 
was performed in TNTProbeTool. There were several cases where probes could not be 
designed under the normal condition, and the Tm was changed to accomplish a probe design. 
A probe designed in TNTProbeTool was only a theoretical suggestion where the software 
program calculated Tm based on e.g. bases, hybridization and nearest-neighbor 
thermodynamic approach. Further test in vitro was performed with similar temperature for all 
probes, however, probed designed with another Tm could be an explanation to why probe did 
not annealed to the target bacterium.  
 
TNTProbeTool could design several probes for one species/genus. It was no possibilities to 
test more than three probes through the present work due to limited time. The election process 
to reduce the number of probes was performed by calculations in TNTProbeTool 
(accomplished by GA). A probe could not be designed if the target bacterium was not present 
in TNTProbeTool. When the software program was made, some 16S rRNA gene sequences 
were not available and could therefor not be incorporated in TNTProbeTool. Probes at higher 
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taxonomic level could not be designed if just one bacterium for the taxonomic level was 
available.   
 
Phylogeny serves to define and relate the diversity of environmental populations. Probes that 
were more directed to identifying phylogenetic groups of rank greater than species provided a 
phylogenetic overview to community structure. The complex microflora of the human gut 
(Bousvaros, et al., 2006) is difficult to study with probes on a species level due to the 
diversity. It was therefor more convenient to have probes specific for major genera and 
groups present in the gut, but there was also interesting to see if any of the reported species 
were present in the feces samples.  
 
TNTProbeTool designs probes based on available sequence information, and in principle it is 
only bacteria incorporated in the software program. Although this could have been a desirable 
situation is this not the whole truth. Unknown bacterial sequences from gut microbiota are 
anonymous information for TNTProbeTool, and when probes were designed, these sequences 
could not be compared. Based on this, there might be unknown bacteria that anneal to the 
designed sequences (probes) in TNTProbeTool.  
 
There are uncertainties related to the use of probes, and descriptions of probe applications are 
important to be able to compare probes from multiple research groups. Probe design, 
identification with different nomenclature and unpublished information according to probes 
(hybridization buffer compositions, target group specificity, etc.) can cause complications. 
Each probe should therefor include information as a standardized name, probe sequence, 
optimal hybridization conditions, intended target group and experimentally validated target 
group specificity (Alm, Oerther, Larsen, Stahl, & Raskin, 1996) to be able to compare 
different probes and hence bacteria.  
 
9.3 Probe tested on capillary gel electrophoresis !
Sixty-nine probes tested on capillary gel electrophoresis (hereafter capillary) were of different 
reasons excluded. Self-hybridized probes were caused by internal regions (intra-molecular 
homologies) of the probe that was used as target (Vebø, et al., 2011) because they formed 
secondary structures. Probe that did not hybridize to target bacterium was caused by either 
probe or template. There could be some errors in the probe sequence based on e.g. defect 
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oligonucleotides (ordered from Thermo Scientific) and will result in no capturing of bacteria. 
In terms of the template, it would be expected to get weak probe signals if the template gave 
weak results from PicoGreen and Gel Electrophoresis (Kreso, 2012). Information obtained 
from PicoGreen and Gel Electrophoresis was just an indication for DNA quantification and 
was not directly associated with the GA-mapTM assay, and were of this reason not reported.  
 
If one probe captured non-target bacterium, which cannot be known before the probes are 
tested several times to confirm the catch, was an indication for an unspecific probe because 
the probe found discriminated sequences among non-target bacteria. The reason for double 
peaks from capillary is not known but is an indication for a non optimal probe (Vebø, 2012). 
Normally this was a recurrent problem for the probe because double peaks occurred in almost 
each case where the probes were tested against different bacteria template. Some problems 
occurred during capillary because the probe did not pass sizing. Software program 
GeneMapper could resolve the problem by identify peaks visually and perform a size standard 
but was unfortunately not always performed. This problem was mainly because of 
GeneMapper and had nothing to do with the probe or the template.    
 
All factors affecting probe and annealing to template are not yet completely known but some 
explanations have been proposed. The sequence designed in TNTProbeTool was only a 
theoretical suggestion and the situation could be different in the real biological world. There 
could also be an error at the sequence as mentioned above. A sequence of 14-25 bp could be 
too short to be able to distinguish 100 % at 16S rRNA level and to further cover the 
identification of the bacterium. If this was the case, one could not be sure whether the 
sequence was the right identification for the bacterium. The Tm was important for the 
hybridization. However, there were no possibilities to spend time on each and every probe to 
treat it with the optimal Tm. This could be performed by the use of gradient PCA but has not 
been in focus by GA because of the amount of probes (Vebø, 2012).  
 
Fifty-seven probes could be used in GA-mapTM IBD assay, and most probes were at species 
level. These probes correlated to an optimal probe and indicated no self-hybridization, 
annealed to discriminatory sequence on target bacterium, and were specific enough to not 
capture the non-target bacteria.  
 
! '+!!
9.4 Partial Least Squares – Discriminant Analysis (PLS-DA) !
In the literature there have been most attention on the pathogenic role of the gut microflora in 
CD (Joossens, et al., 2011; Mondot, et al., 2011; Schwiertz, et al., 2010) and can be related to 
that this disease correlates best to microbiota compared to UC. This could also be confirmed 
in the present work since statistical analysis, based on probe signals, found best correlation 
between CD and non-IBD. A probe signal was an indication for whether a group of bacteria 
was presented in the specific sample, or not. PLS-DA found super-variables who were found 
by using information in one or more response variables, to control separation of the samples 
(Sekelja, 2012), and only informative information was used. Pre-processed data was an 
important step where PLS-DA made calculations to reduce noise and irrelevant variation. 
 
In terms of noise and irrelevant variation there were suggested some explanations. The cohort 
samples were randomly placed on three different plates and each plate was run separately. 
Each time one plate was placed in Magpix instrument there was introduced some small 
changes (noise) that were not a result from biological variation. Noise could be described as 
variation that occurred between the plate/sample as a result of e.g. temperature and pressure in 
the room, variation in pipetting etc. The main difference that occurred between samples, 
which was avoidable, was efficiency of hybridization. From the initial to the final sample was 
analyzed by Magpix instrument took approximately one hour. This introduced variability 
between each well with respect for how long the hybridization took place, hence the amount 
of fluorescence that was used in the hybridization reaction (Sekelja, 2012). 
 
9.4.1 Misclassified samples !
Classification error was based on sensitivity and specificity. Sensitivity reflected percentage 
of IBD patients who were correctly identified as having IBD, while specificity reflected the 
percentage of non-IBD who were correctly identified as not having IBD. Classification error 
indicated how many people that were misclassified by the model. The final model was based 
on GA-mapTM Core assay and GA-mapTM Infant assay because more samples were 
misclassified when GA-mapTM IBD assay was included (Sekelja, 2012). In the perfect 
situation would sensitivity be 100 % and specificity 100 %.  Sensitivity and specificity were 
remarkably higher for GA-mapTM Core assay and GA-mapTM Infant assay, compared to GA-
mapTM IBD assay.  
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To go further in diagnosis situation within the people that were misclassified by the model 
could reveal why some people were perceived as sick even if they were healthy, or opposed. 
This information could be used as an indication for weaknesses of the model so one could 
improve the model. Concerning diagnostic information one could ask some questions. Was 
there any doubt about the diagnosis? Did the person recover during a short time? Had healthy 
misclassified people an infection or another GI disorder? Because of confidentiality and 
assurance according to children included in the present work, no further diagnostic 
information existed.  
 
Classification error can be used as a number that covers the diagnostic tool. In a hypothetical 
situation, the patient will go to the doctor to find out what causes the intestinal problems. 
From a doctor’s point of view there will be questions whether the use of GA-mapTM assay 
will be reliably enough to be used as a tool to see if the symptoms is a result from CD or not. 
In a doubtful situation it can be advantageous to get a classification number that covers the 
GA-mapTM assay to decide if the patient should go further with the test.  
 
GA-mapTM IBD assay gave weak results in analysis report from PLS-DA and was further 
excluded from the statically picture. One reason for this could concern bacteria presented in 
feces samples were not to be captured by probes incorporated in GA-mapTM IBD assay. Most 
likely, bacteria were present in the sample but could not be captured by the probes. The 
literature research ahead of the present work was to identify gastro intestinal bacteria suitable 
for IBD diagnostic. Most of these bacteria were based from adult samples and the situation 
could be different for children and adolescence. It has also been reported in the literature that 
microflora for children/adolescence differ from adult (Agans, et al., 2011). Another reason 
could be due to the probes, because, even though they worked at capillary, the situation could 
be different when probes were tested against cohort at Magpix instrument. There were 
different conditions for Magpix instrument as buffer, temperature, and beads, and the probe 
could respond differently. To get better results of GA-mapTM IBD assay one must optimized 
the probe set, by e.g. new or other probes.  
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9.4.2 Bacteria correlation to IBD and non-IBD !
Repeated use of probes will give knowledge according to the expected target is the actually 
bacterium the probe captures. Based on this, was there more knowledge about infant probe set 
compared to core probe set.  
 
PLS-DA found important bacteria that contributed to separating CD from non-IBD according 
to whether the probe was increased or decreased in relation to the opposite group (CD or non-
IBD). Eubacterium siraeum, Bacteroides sp. 2 2 4, Bacteroides fragilis and Bacteroides were 
bacteria that contributed to non-IBD. These bacteria were obtained from core probe set and 
are largely shared among healthy individuals.  
 
Based on observations from previously work performed by GA are there some probes that 
capture more than one species/genus. Probe IG0011 could basically capture Salmonella, 
Citrobacter, Cronobacter, Enterobacter and Morganella. This was an unspecific probe since 
the probe was expected to identify bacteria at a wide range. There was no possibility to decide 
whether the probe captured one of the mentioned genera or several. These genera could 
basically be observed in both CD and non-IBD direction. In present work, contributed probe 
IG0011 for non-IBD group, but based on weak specificity and identification would there be 
no certainty in relation to the real catch. Salmonella is a known pathogenic bacterium that 
cause local intestinal infection and Salmonellosis is essentially a food-borne infectious 
disease (Granum, 2007). However, the probe would not capture Salmonella since feces 
samples were collected for microbiological investigations in advance, to exclude infectious 
causes, and would have been revealed during this process. 
 
IG0081 was named with Streptococcus agalactiae and Eubacterium rectale and contributed 
to non-IBD group. Eubacterium rectale is clustered in Clostridium cluster XIVa and reported 
as more prevalent in CD (Cucchiara, et al., 2009) and should therefor not be headed in the 
direction against non-IBD. 
 
Clostridium butyricum, Finegoldia magna and Collinsella aerofaciens were in present work 
directed to contribute for CD. These bacteria is basically considered as prevalent intestinal in 
healthy individuals (Wang, Beggs, Erickson, & Cerniglia, 2004) and the results were not as 
expected. 
! (.!!
Several bacteria that contributed in direction for CD were bacteria obtained from the core 
probe set. Bacteroides caccae, Bacteroides intestinalis, Ruminococcus/Blautia hansenii, and 
Subdoligranulum variable/Faecalibacterium prausnitzii are common bacteria found among a 
healthy human gut (Qin, et al., 2010) and uncertainties were related to why they were 
obtained and contributed to CD. However, Faecalibacterium prausnitzii is reported as 
decreased in CD (Joossens, et al., 2011). Alistipes putredinis and Ruminococcus torques are 
two common intestinal bacteria (Qin, et al., 2010) but are reported for CD patients as 
decreased (Mondot, et al., 2011) and increased (Martinez-Medina, Aldeguer, Gonzalez-Huix, 
Acero, & Garcia-Gil, 2006), respectively. E. coli is a bacterium that frequently are reported, 
especially in CD. Even though the bacterium was not presented in loading plot, the bacterium 
could be presented in feces samples but did not distinguish during statistical evaluation. More 
information about reduced or increased ratio should have been included to get more 
information. All one could say was that these bacteria contributed more in one or the other 
direction. More knowledge about the probe captures should however be explored before one 
could go further to see if the bacteria have decreased or increased.  
 
There were different reasons why bacteria directed for CD and non-IBD were obtained among 
each other. A reason could be that the bacteria collected from cohort were taken in an early 
stage of the disease course and that these bacteria would increase or decrease in a later course 
of the disease. The time one intestinal goes from normal to more headed for CD is most likely 
to be performed during a period. This is also to be noticed when different studies have been 
reported different bacteria. Most of the bacteria are reported later in the course of the disease 
and after medication and treatments are performed at the patients and bacteria can be affected 
by the treatments. Even though bacteria revealed in present study could not be compared with 
previous studies, there was still possible to distinguish between people suffering from CD and 
non-IBD.  
 
Based on observed differences between CD and non-IBD from present study, many of the 
bacteria were obtained from a common human intestinal and no specific pathogenic bacterium 
was obtained. This might indicate that there was an alteration of the already presented 
bacteria in the intestinal, because genetically predisposed individuals may appear to lose the 
normal tolerance to commensal bacteria, which leads to an elevated inflammatory response.  
 
! (%!!
10 RECOMMENDATION FOR FURTHER WORK !
For further work one could include more cohort samples to strengthen the results. Replace 
non-IBD with healthy subjects could also be a recommendation since non-IBD may have a 
diagnostic potential, and moreover defect the results. For detection of bacteria through the 
pathogenesis of IBD, there could be interesting to test the cohort after a time period to see if 
the same bacteria were presented. There should also be included information regarding the 
ratio between decreased and increased.  
   
GA-mapTM IBD assay need to be optimized in the future to get better signals by the probes. 
This could be accomplished by trying different fluorescence to strengthen the probe signals, 
or change hybridization conditions. Further needs are based on knowledge behind the probes 
(what they captures), to compare the results from other studies.  
 
As there were more probes designed than could be evaluated, there could be missing 
information. Further testing of several probes to optimize GA-mapTM IBD assay could be an 
opportunity to reveal more bacteria correlated to IBD. Moreover, strengthen the identification 
of the gut bacteria by using different genes, other than 16S rRNA gene, by extend the assay to 
investigate the biodiversity of the gut microbiota. 
 
11 CONCLUSION 
A tool based on GA-mapTM technology was designed and revealed differences between non-
IBD and patients who suffer from CD, and the model gave a classification error by 16 %. An 
altered composition of the common bacteria in the intestinal tract seems responsibly for CD.  
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13 APPENDICES 
APPENDIX A - Diagnostic criteria according to Porto criteria 
 
Due to lack of consistent data from different studies there is important to have a common 
understanding for inflammatory bowel disease. Porto criteria was therefor developed where 
an agreement for diagnostic criteria was established for children (Escher, et al., 2005). 
Children from IBSEN-II were classified as CD, UC or IBD unclassified (IBDU) according to 
Porto criteria with following criteria (Escher, et al., 2005). 
 
The presence of two or more of the following criteria were diagnosed CD 
• Clinical features including abdominal pain, diarrhoea and weight loss. 
• Macroscopic appearance at operation or endoscopy: segmental, discontinuous, and/or 
patchy lesions with or without rectal involvement, discrete or apthous ulcerations, 
fissuring or penetrating lesions, cobblestone or strictures. 
• Radiological evidence of stenosis in the small bowel, segmental colitis or findings of 
fistulae. 
• Histologic evidence of transmural inflammation or epithelial granulomas with giant 
cells.  
The presence of three or more of the following criteria were diagnosed UC 
• A history of diarrhoea and or blood/pus in stool. 
• Macroscopic appearance at endoscopy, with continuous mucosal inflammation 
affecting the rectum in continuity with some of the entire colon. 
• Microscopic features on biopsy compatible with UC. 
• No suspicion of CD on small bowel roentgenography, ileocolonscopy, or biopsy. 
Patients diagnosed with IBDU  
• Patients with inconclusive or divergent endoscopy and histopathology according to 
CD or UC criteria were classified as IBDU. 
 
Children who did not fulfilled the diagnostic criteria for IBD and who displayed no evidence 
of IBD, were included as a patient control group (non-IBD) (Perminow, Brackmann, et al., 
2009). 
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APPENDIX B - MAGPIX instrument 
 
The heart of a MAGPIX instrument is build up of a sample chamber, magnet, light-emitting 
diodes (LEDs) and CCD chamber (Figure A1). The instrument analyzes 96 samples in a 
microtiter plate where one and one sample is analyzed at a time. The whole process takes 
approximately one hour. One well contains a probe set in addition to one sample from cohort. 
In each well there are at least 50 microsphere per one bacterium and normally the number of 
microspheres are more than those who will be depicted. A sample probe (name of the 
instrument that retrieves the mixtures) goes into each well on the microtiter plate and absorbs 
totally 50 µl microspheres (mixture of the different microspheres). The microspheres will 
further be transported in the optics module where a magnet holds the magnetic microspheres 
in place while a red and green LED illuminate them. The red laser is first out to measure 
internal dye fluorescence for classification and distinguish the 50 different microspheres. 
Next, the green laser excites surface and reports fluorescence. When the magnet holds the 
magnetic microspheres, the magnetic microspheres are washed before illumination to reduce 
disturbance. During each illumination, the magnetic microspheres are imaged. After the 
images are recorded, the magnet withdraws and releases the microspheres (Luminex, 2011). 
 
 
 
 
 
 
Figure A1: The heart of MAGPIX instrument is build up by a sample chamber, magnet, LED and CCD chamber 
("Multiplexed Solutions for Life - Luminex Corporation," 2012) where the microspheres is illuminated and analyzed.  
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APPENDIX C – TNTProbeTool 
 
TNTProbeTool is based on principal component analysis (PCA) for discrimination and 
classification of bacteria. PCA is a multivariate statistical method that visualizes the main 
structure in data with redundancies, and is well suited to build models that can be used for 
classification (Rudi, Zimonja, & Næs, 2006). One bacterium and its related sequence is 
represented as one spot in the PCA-plot in TNTProbeTool. Nearby sequences will fall in the 
same area of the PCA-plot and forms clusters on the basis of 16S rRNA phylogeny as seen for 
the four phyla, Actinobacteria, Firmicutes, Protebacteria and Bacteroides (Figure A2). In 
order to classify sequences for phylogeny, the sequences are transformed to pentamer 
frequency and then performed PCA on the pentamer frequency. TNTProbeTool uses the 
pentamer frequency to make a PCA-plot but the program has access to the real sequence for 
each bacterium at about 1,500 bp (16S rRNA gene) (Sekelja, 2012). The user defines target 
bacterium among target group and leaves all other bacteria as non-target (Figure A3). When 
the target bacterium is chosen, the program makes a probe suggestion. 
 
!
Figure A2: Score plot of the four phyla presented from the human GI tract where they form clusters (Vebø, et al., 2011).  
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Figure A3: Illustration of TNTProbeTool software program where bacteria are represented in a PCA-plot based on their 
pentamer-frequencies. Defined target and non-target groups are shown in green and red, respectively (Vebø, et al., 2011). 
 
To be able to design a probe set for identifying bacteria related to inflammatory bowel disease 
it is a prerequisite to have DNA sequences (16S rRNA gene) of all bacteria expected to find 
in the human gut, incorporated in TNTProbeTool. For this purpose there have been used 
several sources: The Human Microbiome Project, articles on the human intestinal microbiota 
published in international journals, sequence databases (NCBI and RDP10) and results from 
Genetic Analysis’s own research (Vebø, et al., 2011). 
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APPENDIX D – Examples on result from capillary gel electrophoresis  
 
Probes are tested against self-hybridization, target bacterium, and non-target bacteria. 
Examples for results from gel electrophoresis can be seen in Figure A4. Hybridization 
requires signals up to 7,000 – 8,000. If no signal is present one can observe noise that reflect 
signals up to 20.  
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Figure A4: Examples on results from gel capillary electrophoresis. I – Hybridization, e.g. a probe has hybridized to target 
bacterium, II – No hybridization, e.g. probe tested for self-hybridization, III – Double peak 
"
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APPENDIX E – Multivariate data analysis 
 
E.1 Principal Component Analysis (PCA) 
PCA is used to compress large amount of data without loosing significant information. PCA 
can be used to identify patterns in data, and expressing the data in such a way, to highlight the 
structures, similarities, trends, outliers (describes a spot that lies outside the overall pattern of 
observations), differences or relationship between samples and variables (Nortvedt, et al., 
1996). PCA describes the variation among the data by finding super-variables that maximize 
the explained variance in the data (Sekelja, 2012). 
 
Samples form a swarm in a 3-dimentional space. A line seeks through the swarm and 
describes most of variance after the data are centralized. The meaning of centralized data is 
that the origin in the coordinate is moved to the average of all the samples. The first principal 
component (PC1) has the largest possible variance (that is, accounts for much of the 
variability in the data) in the length of the swarm. The second principal component has the 
highest variance possible under the constraint that it is orthogonal (perpendicular) to the 
preceding component (PC1) and explains the direction with second most variance (Nortvedt, 
et al., 1996). Error or noise that cannot be modeled as reasonable structures is called residual 
(Sekelja, 2012). 
 
To get an overview of the data, it is often informative to plot two or three objects/variables in 
a coordinate system (usually this is the main variation in the data), to see how they are placed 
in relation to each other (Nortvedt, et al., 1996). This is performed by use of super-variables 
on the basis of the original variables. Two different plots (score plot and loading plot) are 
used to present super-variable results, and can later be compared.  
 
E.2 Partial Least Squares – Discriminant Analysis (PLS-DA) 
PLS-DA is a classical regression that decomposes a data matrix in a similar way as the PCA 
but uses additional information (such as diagnose) to find super-variables. PLS-DA has also 
much in common with the classical discriminant analysis method LDA (Linear discriminant 
analysis). LDA finds linear combinations of variables that characterize or separates two or 
more samples, based on one or more response variables, and the resulting combination can be 
used as a linear classifies. However, LDA can become unstable if the correlation between 
variables (probes) is high. The main difference between PLS-DA and LDA is that PLD-DA 
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uses super-variables that are found by using information in one or more response variables, to 
control the separation of the samples (Sekelja, 2012). 
 
 
APPENDIX F – Pre-processing and plate variation 
 
Samples are randomly distributed into different plates. Each time one plate is placed on 
Magpix instrument there will be introduced some small changes (noise) that are not a result of 
biological variation. Noise can be described as variations that occurs between the samples as a 
result of e.g. temperature and pressure in the room, the time each plate is deferred before it is 
analyzed, variation in pipetting, etc. The small differences that occur naturally between the 
plates are reduced trough pre-processing, which means that signals (as a consequence from 
the noise), not relevant to the analysis, is deleted. In each well there is a hybridization control 
probe that is used to control the efficiency of hybridization, that is, the amount of used 
fluorescence during hybridization reaction. The Magpix instrument use less than one minute 
for the derivation of signal in each well, which introduces variability between each well (from 
well 1A to well 12H = approximately one hour) with respect to how long they will wait and 
hence, how long the hybridization takes place in each well (Sekelja, 2012). 
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APPENDIX G – Classification 
 
In a perfect situation there is possible to distinguish 100 % between healthy and sick people, 
as seen in Figure A5 where the two groups are placed at each side for the test cutoff. 
 
 !
 
 
 
 
 
 
Figure A5: 100 % distinguish between healthy and sick people, presented with 200 people in each group. Illustration 
(Schmidt, 2012) is a made example and do not represent the present work.     
 
Unfortunately, this is not the reality. A more realistic model would look more like figure A6. 
In this model, 40 healthy people (green area) are classified as sick (false negative), while 52 
sick people (yellow area) are classified as healthy (false positive). Classification error is in 
this case 0,23 ((40+52)/400) or 23 %.  
 
 
 
 
 
 
 
 
 
 
 
Figure A6: Healthy and sick people together with misclassified people (yellow and green area). Illustration (Schmidt, 2012) 
is a made example and do not represent the present work.    
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APPENDIX H – Cohort 
 
Cohort identification and diagnosis (UC, CD, IBDU and non-IBD).  
 
Cohort ID Diagnosis: 1= UC, 2=CD, 3= IBDU, 4=NonIBD Sick=1, Healthy=2 
28 2 1 
35 4 2 
50 4 2 
58 4 2 
79 1 1 
87 4 2 
104 3 1 
111 2 1 
136 4 2 
158 4 2 
163 2 1 
180 2 1 
191 4 2 
192 1 1 
195 4 2 
202 2 1 
207 4 2 
1013 1 1 
1028 2 1 
2024 2 1 
6006 4 2 
6010 2 1 
6023 1 1 
6033 1 1 
6035 2 1 
6036 2 1 
7 2 1 
20 4 2 
32 4 2 
54 4 2 
72 4 2 
88 4 2 
119 1 1 
188 2 1 
196 4 2 
198 1 1 
205 4 2 
206 2 1 
1005 2 1 
2025 3 1 
6001 1 1 
6003 2 1 
6007 1 1 
6009 4 2 
6013 2 1 
6015 4 2 
6017 1 1 
6019 2 1 
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6026 1 1 
6028 2 1 
6030 2 1 
6038 1 1 
6039 2 1 
71 2 1 
99 4 2 
126 1 1 
130 4 2 
131 2 1 
172 2 1 
181 2 1 
187 4 2 
201 4 2 
1006 4 2 
1030 2 1 
6004 4 2 
6005 1 1 
6008 4 2 
6011 1 1 
6014 3 1 
6016 4 2 
6018 2 1 
6021 4 2 
6022 2 1 
6032 2 1 
6034 2 1 
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APPENDIX I – List of species-probes designed in TNTProbeTool 
 
Overview of probes designed at species level in TNTProbeTool. Presents bacterium (target) 
name and number of designed probes, and comments to probe search.  
 
 
Bacteria – species level 
 
Number of probe designed 
 
Comment to probe search 
Acidimicrobidae bacterium Ellin7143 12 probes  
Acinetobacter junii 15 probes  
Actinobacterium GWS-BW-H99  Not found in target group 
Actinomyces oxydans  Not found in target group 
Akkermansia muciniphila 22 probes  
Alistipes onderdonkii  Not found in target group 
Alistipes putredinis  Probe exists at GA  
Bacillus licheniformis 2 probes  
Bacillus megaterium 4 probes  
Bacterium mpn-isolate group 18   Not found in target group 
Bacterium mpn-isolate group 19   Not found in target group 
Bacterium mpn-isolate group 5 4 probes Nearby probes deleted  
Bacteroides acidofaciens 3 probes  
Bacteroides distasonis  Probe exists at GA  
Bacteroides fragilis  Probe exists at GA  
Bacteroides ovatus  Probe exists at GA  
Bacteroides stercoris  Probe exists at GA  
Bacteroides thetaiotaomicron 4 probes  
Bacteroides uniformis  Probe exists at GA  
Bacteroides vulgatus  Probe exists at GA  
Bacteroides zoogleoformans 2 probes  
Bi!dobacterium adolescentis 3 probes  
Bifidobacterium bifidum 2 probes  
Bi!dobacterium infantis 5 probes  
Bifidobacterium longum  Probe cannot be designed, neither 55 °C 
Blautia coccoides       2 probes  
Butyrate-producing bacterium L2-7 3 probes  
Butyrate-producing bacterium SR1/1   Not found in target group 
Butyrivibrio fibrisolvens 6 probes  
Catenibacterium mitsuokai 9 probes  
Clostridium aminophilum 3 probes  
Clostridium clostridiiforme 2 probes  
Clostridium dificile 6 probes  
Clostridium leptum         Probe exists at GA  
Clostridium limosum  Not found in target group 
Clostridium litorale         Not found in target group 
Clostridium lituseburense       2 probes  
Clostridium methylpentosum       2 probes  
Clostridium nexile        Probe exists at GA  
Clostridium orbiscindens        2 probes  
Clostridium ramosum    3 probes  
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Clostridium sp. SS2/1 14 probes  
Clostridium spiroforme       Not found in target group 
Clostridium thermosuccinogenes  Not found in target group 
Clostridium viride        5 probes  
Clostridium xylanolyticum 2 probes  
Dialister invisus 7 probes  
Dorea formicigenerans  Probe exists at GA  
Dorea longicatena  Probe exists at GA  
Drinking water bacterium Y7 19 probes  
Enterobacter cowanii 2 probes  
Enterococcus durans 1 probe  
Enterococcus faecalis  Probe exists at GA  
Enterococcus faecium 2 probes Nearby probes deleted 
Enterococcus saccharolyticus 3 probes  
Eubacterium biforme 10 probes  
Eubacterium cylindroids  12 probes  
Eubacterium desmolans         Not found in target group 
Eubacterium rectale        Probe exists at GA  
Faecalibacterium prausnitzii        Probe exists at GA  
Gamma proteobacterium DD103 13 probes Named Gammaproteobacteria in further 
testing, but this probe includes only 
Gamma proteobacterium DD103 
Helicobacter bilis 1 probe  
Helicobacter canis 1 probe   
Helicobacter ganmani 5 probes  
Helicobacter hepaticus 1 probe Nearby probes deleted 
Helicobacter trogontum 2 probes Nearby probes deleted 
Klebsiella pneumonia 1 probe Nearby probes deleted 
Lachnospira pectinoschiza 2 probes  
Lachnospiraceae bacterium A4  8 probes  
Lachnospiraceae Incertae Sedis 1 probe Probe designed at 50-55 °C, unspecific 
Lactobacillus acidophilus 1 probe  
Lactobacillus fermentum 3 probes  
Lactobacillus johnsonii 7 probes  
Lactobacillus reuteri 1 probe  
Lactobacillus ruminis 4 probes  
Listeria innocua  1 probe Design is not very specific and capture 
other Listeria species  
Listeria ivanovii  1 probe Design is not very specific and capture 
other Listeria species 
Listeria monocytogenes  1 probe Design is not very specific and capture 
other Listeria species 
Listeria seeligeri 1 probe Design is not very specific and capture 
other Listeria species 
Listeria welshimeri  1 probe Design is not very specific and capture 
other Listeria species 
Nocardioides sp. NS/27 11 probes  
Novosphingobium sp. K39 12 probes  
Oscillibacter valericigenes  5 probes  
Oscillospira guilliermondii        1 probe  
Prevotella bivia 7 probes  
Prevotella intermedia 5 probes  
Prevotella nigrescens 4 probes  
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Prevotella ruminicola 9 probes  
Proteus vulgaris  5 probes Probe designed at 55 °C, not specific 
Pseudomonas straminea 2 probes  
Roseburia cecicola       7 probes  
Roseburia hominis 2 probes  
Ruminococcus albus 4 probes  
Ruminococcus bromii        3 probes  
Ruminococcus callidus 13 probes  
Ruminococcus gnavus  Probe exists at GA  
Ruminococcus obeum      1 probe  
Ruminococcus torques  Probe exists at GA  
Sphingomonas  paucimobilis 13 probes  
Sphingomonas sp. AO1  Not found in target group 
Sutterella wadsworthensis 15 probes  
Vibrio campbellii 1 probe Nearby probes deleted 
Wolinella succinogenes 2 probes  
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APPENDIX J – List of genus/class/order-probes designed in TNTProbeTool 
 
Bacteria overview from probe designed in TNTProbeToll at genus/class/order level with 
bacteria (target) name, number of designed probes and comments to probe search.  
 
Bacteria - 
genus/class/order level 
Number of designed 
probes 
 
Comment to probe search 
Aeromonas (genus) 2 probes  
Alistipes (genus)  Not found in target group 
Alphaproteobacteria (class)  Not found in target group 
Asteroleplasma (genus) 32 probes  
Bacillus (genus) 1 probe Includes Bacillus cereus and Bacillus anthracis, designed at 55 
°C 
Bacteroides (genus)  Probe exists at GA  
Bifidobacterium (genus) 3 probes  
Blautia (genus) 1 probe  
Campylobacter (genus) 1 probe  
Citrobacter (genus) 1 probe Includes Citrobacter amalonaticus and Citrobacter diversus, 
designed at 58 °C 
Clostridium (genus)  Probe exists at GA  
Dialister (genus) 5 probes  
Dorea (genus) 1 probe Designed at 55 °C 
Enterococcus (genus) 1 probe Includes Enterococcus avium, Enterococcus durans, 
Enterococcus faecium, Enterococcus raffinosus and 
Enterococcus saccharolyticus  
Erysipelotrichi (class)  Not found in target group 
Escherichia (genus) 6 probes  
Eubacterium (genus) gr 1 1 probe Includes Eubacterium rectale, Eubacterium rectale and 
Eubacterium ventriosum 
Eubacterium (genus) gr 2 8 probes Includes Eubacterium biforme, Eubacterium cylindroides and 
Eubacterium dolichum 
Fusobacterium (genus) 1 probe Designed at 55 °C 
Haemophilus (genus) 2 probes Includes Haemophilus influenzae and Haemophilus 
aggregatibacter 
Helicobacteraceae (family) 1 probe Includes Helicobacter billis, Helicobacter canadensis, 
Helicobacter canis,Helicobacter cinaedi, Helicobacter ganmani, 
Helicobacter hepaticus, Helicobacter pullorum, Helicobacter 
pylori, Helicobacter trogontum and Helicobacter winghamensis 
Lachnospiraceae (family)  Probe cannot be designed 
Lactobacillus (genus) 1 probe Includes Lactobacillus fermentum, Lactobacillus ultunensis, 
Lactobacillus ruminis, Lactobacillus salvivarius, Lactobacillus 
acidophilus, Lactobacillus helveticus, Lactobacillus amylolytic, 
Lactobacillus reuteri, Lactobacillus antri, Lactobacillus 
johnsonii and Lactobacillus paraplantarum 
Listeria (genus) 2 probes  
Mannheimia (genus) 5 probes Includes Mannheimia glucosida and Mannheimia haemolytica 
Parabacteroides (genus) 2 probes  
Prevotella (genus) 2 probes  
Roseburia (genus) 4 probes  
Ruminococcus (genus) 2 probes Includes Ruminococcus lactaris, Ruminococcus lactaris 
ATTCC, Ruminococcus torques and Ruminococcus torques 
ATCC 
Shigella (genus) 1 probe Designed at 55 °C, nearby probes deleted 
Sphingomonas (genus) 1 probe No genus probe designed, only Sphingomonas paucimobilis 
included. Nearby probes deleted 
Subdoligranulum (genus)  Probe exists at GA  
Veilonella (genus) 8 probes  
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APPENDIX L – Bacteria for core probe set (GA-mapTM Core assay) 
 
 
CORE - probe set 
Bacteria Probe ID 
Alistipes putredinis (Parabacteroides distasonis) AG0339 
Anaerotruncus colihominis AG0342 
Bacteroides caccae? AG0350 
Bacteroides capillosus (Clostridium leptum) AG0353 
Bacteroides dorei group/Bacterioides sp. D4 AG0358 
Bacteroides fragilis AG0377 
Bacteroides intestinalis? AG0383 
Bacteroides pectinophilus (Suboligranulum variable) AG0393 
Bacteroides sp 2 2 4/Bacteroides ovatus/Bacteroides sp. D1 (Bacteroides thetaiotaomicron) AG0396 
Bacteroides sp 4 3 47FAA/Bacteroides vulgatus (Parabacteroides distasonis/johnsonii) AG0403 
Bacteroides sp 9 1 4? AG0406 
Bacteroides stercoris? AG0416 
Bacteroides vulgatus/Bacteroides caccae/Bacteroides intestinalis +++ AG0443 
Blautia hansenii AG0447 
Butyrivibrio crossotus AG0454 
Clostridium asparagiforme? AG0457 
Clostridium leptum (Ruminococcus bromii) AG0470 
Clostridium sp M63 Butyrate Producing AG0488 
Clostridium scindens AG0508 
Clostridium sp L250 AG0515 
Collinsella aerofaciens? AG0531 
Coproccoccus comes AG0495 
Coprococcus eutactus AG0569 
Dorea formicigenerans (Dorea longicatena) AG0581 
Dorea longicatena (Ruminococcus bromii) AG0587 
Enterococcus faecalis AG0591 
Eubacterium hallii AG0608 
Eubacterium rectale? AG0620 
Eubacterium siraeum AG0638 
Eubacterium siraeum? AG0439 
Eubacterium ventriosum AG0642 
Faecalibacterium cf prausnitzii/Subdoligranulum variabile (Eubacterium siraeum) AG0651 
Holdemania filiformis AG0654 
No signal? AG0756 
Parabacteroides distasonis? AG0679 
Parabacteroides johnsonii/Parabacteroides merdae AG0686 
Parabacteroides merdae AG0693 
Roseburia intestinalis (Clostridium sp. SS2) AG0701 
Ruminococcus gnavus (Eubacterium ventriosum) AG0703 
Ruminococcus lactaris AG0707 
Ruminococcus torques AG0714 
Streptococcus thermophilus/Coprococcus comes/Clostridium nexile  AG0732 
Subdoligranulum variabile AG0744 
Universal UNI04 
! *+!!
APPENDIX M – Bacteria for infant probe set (GA-mapTM Infant assay) 
 
INFANT - probe set 
Bacteria Probe ID 
Actinobacteria IG0028 
Anaerococcus prevotii IG0095 
Bacteroides IG0060 
Bifidobacterium (not B. breve) IG0027 
Bifidobacterium (not B. longum) IG0030 
Clostridiales and Veillonella IG0058 
Clostridiales and Veillonellaceae IG0044 
Clostridium butyricum IG0163 
Clostridium sporogenes IG0103 
Enterococcus faecalis IG0171 
Finegoldia magna IG0107 
Firmicutes (separates on Listeria, Veillonella and some Clostridiales) IG0023 
Firmicutes (separates on Streptococcus and some Clostridiales) IG0012 
Gamma-proteo group IG0178 
Gamma-proteobacteria subgroup IG0056 
Gemella IG0042 
Haemophilus IG0008 
Klebsiella  pneumonia/Aeromonas IG0181 
Klebsiella oxytoca/Pantoea agglomerans IG0195 
Lactobacilli IG0053 
Listeria sp. (and E. coli/Shigella) IG0021 
Proteobacteria IG0005 
Pseudomonas/Morganella morganii IG0039 
Salmonella/Citrobacter/Cronobacter/Enterobacter/Morganella IG0011 
Serratia  marcescens IG0204 
Shigella and E.coli  IG0133 
Staphylococcus and Gemella IG0024 
Staphylococcus epidermidis, Eubacterium rectale, Clostridium SS2, Streptococcus 
agalactiae 
IG0063 
Streptococcus ("-haemolytic) IG0197 
Streptococcus (#-haemolytic groupA and B, "-haemolytic) IG0079 
Streptococcus (#-haemolytic groupB, "-haemolytic) IG0022 
Streptococcus agalacticae and Eubacterium rectale IG0081 
Streptococcus sanguinis and thermophilus IG0020 
Universal UNI04 
Veillonella IG0051 
! *,!!
 
APPENDIX K - Probe overview from capillary gel electrophoresis (target-bacteria)
Color code: Blue - optimal probe. Yellow - excluded due to self-hybrid, double top, weak signal. Green - tested at GA before. Grey - excluded, bacterium not available. Pink - problem with LIZ or signal under cut-off
Phyla: Genus(g), Species(s), Class(c) 
B. - Bifidobacterium
Color code ID Target info Phyla
Self-hybrid 
(Yes/No) Comment self-hybrid Target 1 bacterium Sign. 1 Target 2 bacterium Sign. 2 Target 3 bacterium Sign. 3 Target 4 bacterium Sign. 4 Target 5 bacterium Sign. 5 Target 6 bact. Sign. 6 Target 7 bact. Sign. 7 Target 8 bact. Sign. 8 Target 9 bact. Sign. 9 Target 10 bact. Sign. 10 Target 11 bacterium Sign. 11
AG0770 Acidimicrobidae bacterium Ellin s N Target bacterium not available
AG0774 Acidimicrobidae bacterium Ellin s N Target bacterium not available
AG0775 Acidimicrobidae bacterium Ellin s N small peak at >100 bp Target bacterium not available
AG0777 Acinetobacter junii s N small peak at >100 bp Acinetobacter junii 7434
AG0784 Acinetobacter junii s N small peak at >100 bp Acinetobacter junii 4273
AG0783 Acinetobacter junii s N small peak at >100 bp Acinetobacter junii 1792/1483
AG0792 Aeromonas g Y
>200 peak at 100 bp + 
>1000 peak at 200 bp
AG0793 Aeromonas g N small peak at >100 bp Aeromonas veronii 1251 Aeromonas caviae 1714
AG0815 Akkermansia muciniphila s N Akkermansia muciniphila 2890
AG0798 Akkermansia muciniphila s N Akkermansia muciniphila 3119
AG0801 Akkermansia muciniphila s N Akkermansia muciniphila 7331
AG1226 Alistipes g N Genus probe excluded
AG1225 Alistipes onderdonkii s N Alistipes onderdonkii 8975
Alistipes putredinis s
AG0819 Asteroleplasma g N Target bacterium not available
AG0827 Asteroleplasma g N small peak at >100 bp Target bacterium not available
AG0829 Asteroleplasma g N Target bacterium not available
AG0848 Bacillus g N small peak at >100 bp Genus probe excluded
AG0849 Bacillus licheniformis s N small peak at >100 bp Bacillus licheniformis 1153 Bacillus licheniformis no signal
AG0850 Bacillus licheniformis s N Bacillus licheniformis 511 Bacillus licheniformis no signal
AG0851 Bacillus megaterium s N Bacillus megaterium 2591
AG0852 Bacillus megaterium s N Bacillus megaterium 840
AG0854 Bacillus megaterium s N Bacillus megaterium 6612
AG0856 Bacterium mpn-isolate group 5 s N Target bacterium not available
AG0857 Bacterium mpn-isolate group 5 s N small peak at >100 bp Target bacterium not available
AG0858 Bacterium mpn-isolate group 5 s N small peak at >100 bp Target bacterium not available
AG0859 Bacteroides acidofaciens s N 700 peak at >100 bp Bacteroides acidofaciens 39
AG0860 Bacteroides acidofaciens s N Bacteroides acidofaciens 76/94
AG0861 Bacteroides acidofaciens s N Bacteroides acidofaciens 2736
(Para)Bacteroides distasonis s
Bacteroides fragilis s
Bacteroides ovatus s
Bacteroides stercoris s
Bacteroides thetaiotaomicron s
Bacteroides uniformis s
Bacteroides vulgatus s
AG0862 Bacteroides zoogleoformans s N Bacteroides zoogleoformans 2474
AG0863 Bacteroides zoogleoformans s N Bacteroides zoogleoformans 7274
AG0864 Bifidobacterium g N small peak at >100 bp  Bifidobacterium adolescentis                                     no signalB. a gulatum 1700 B. animalis 2200 B. bifidum 2000  B. breve 2400 B. catenulatum 1600 B. dentium 2500 B. gallicum
double 
top B. infantis 1500 B. longum 1800 B. pseudocatenulatum 1000
AG0865 Bifidobacterium g N Bifidobacterium adolescentis 5955 B. angulatum 7559 B. animalis subsp lactis 7339 B. bifidum 8333  B. breve 8195 B. catenulatum 4443 B. dentium 6245 B. gallicum 7065 B. infantis 7830 B.longum 7977 B. pseudocatenulatum 7022
AG0867 Bifidobacterium adolescentis s N Bifidobacterium adolescentis 1157/1900/984 B. adolescentis
AG0868 Bifidobacterium adolescentis s N small peak at 22 bp Bifidobacterium adolescentis 720/1681 B. adolescentis
AG0870 Bifidobacterium bifidum s N Bifidobacterium bifidum 4430
AG0871 Bifidobacterium bifidum s N Bifidobacterium bifidum 2109
AG0872 Bifidobacterium infantis s N Bifidobacterium infantis 30
AG0873 Bifidobacterium infantis s N Bifidobacterium infantis 46
AG0876 Bifidobacterium infantis s N Bifidobacterium infantis 462
AG1224 Blautia g N Genus probe excluded
AG1230 Blautia g N Genus probe excluded
AG0878 Blautia coccoides s N Blautia coccoides 690
AG0879 Blautia coccoides s N Blautia coccoides 2576
AG1227 Blautia schinkii s N Blautia schinkii 1977/2137
AG1228 Blautia schinkii s N Blautia schinkii 6943
AG1229 Blautia schinkii s N Blautia schinkii 8366
AG0880 Butyrivibrio fibrisolvens s N Butyrivibrio fibrisolvens 726/262 Butyrivibrio fibrisolvens
AG0881 Butyrivibrio fibrisolvens s N Butyrivibrio fibrisolvens 668/239 Butyrivibrio fibrisolvens
AG0884 Butyrivibrio fibrisolvens s N Butyrivibrio fibrisolvens 914/365 Butyrivibrio fibrisolvens
AG0886 Campylobacter g N Campylobacter coli 427 Campylobacter concisus 2216 Campylobacter curvus 266
Campylobacter 
hominis no signal
Campylobacter 
jejuni 2303
Campylobacter 
upsaliensis 4287
AG0893 Catenibacterium mitsuokai s N Catenibacterium mitsuokai 2236/2377
AG0895 Catenibacterium mitsuokai s N Catenibacterium mitsuokai 7846
AG0894 Catenibacterium mitsuokai s N Catenibacterium mitsuokai 3791
AG0896 Citrobacter g N Citrobacter braakii 555 Citrobacter freundii 15 Citrobacter youngae 480
AG0898 Clostridium  gr 2 g N probe excluded
AG0899 Clostridium aminophilum s N Clostridium aminophilum 3048
AG0900 Clostridium aminophilum s N Clostridium aminophilum 4357
AG0902 Clostridium clostridioforme s N Clostridium clostridioforme 31
AG0903 Clostridium clostridioforme s N Clostridium clostridioforme no signal
AG0905 Clostridium difficile s N Clostridium difficile 1441
AG0907 Clostridium difficile s N Clostridium difficile 3494
AG0908 Clostridium difficile s N Clostridium difficile 6342
AG0897 Clostridium gr 1 g N probe excluded  
Clostridium leptum       s
AG1231 Clostridium limosum s N Target bacterium not available
AG0910 Clostridium lituseburense s N Clostridium lituseburense 1164/653/377 Clostridium lituseburense
AG0911 Clostridium lituseburense s N Clostridium lituseburense 1228/1042/466 Clostridium lituseburense
AG0912 Clostridium methylpentosum s N Clostridium methylpentosum 7876
AG0913 Clostridium methylpentosum s N Clostridium methylpentosum 1607
Clostridium nexile      s
AG0914 Clostridium orbiscindens s N Clostridium orbiscindens 1165/1800/665 Clostridium orbiscindens
AG0915 Clostridium orbiscindens s N Clostridium orbiscindens no signal Clostridium orbiscindens
AG0917 Clostridium ramosum s N Clostridium ramosum 693/754
AG0916 Clostridium ramosum s N Clostridium ramosum 5887
AG0918 Clostridium ramosum s N Clostridium ramosum 4142
AG1221 Clostridium sp. SS2-1 s N Clostridium sp. SS2-1 no signal
AG1223 Clostridium sp. SS2-1 s N Clostridium sp. SS2-1 no signal
AG1219 Clostridium sp. SS2-1 s - no signal Clostridium sp. SS2-1 2721
AG0922 Clostridium viride s N Clostridium viride 385/306
AG0919 Clostridium viride s N Clostridium viride 7320
AG0921 Clostridium viride s N Clostridium viride 9221
AG0924 Clostridium xylanolyticum s N Clostridium xylanolyticum 1314/1188
AG0925 Clostridium xylanolyticum s N Clostridium xylanolyticum 194
Coprococcus g
AG0926 Dialister g N Genus probe excluded
AG0928 Dialister g N Genus probe excluded
AG0930 Dialister g N Genus probe excluded
AG0932 Dialister invisus s N Dialister invisus 1931
AG0931 Dialister invisus s N Dialister invisus 6122
AG0938 Dorea g N Genus probe excluded
Dorea formicigenerans s
Dorea longicatena s
AG0939 Drinking water bacterium Y7 s N Target bacterium not available
AG0942 Drinking water bacterium Y7 s N Target bacterium not available
AG0948 Drinking water bacterium Y7 s N Target bacterium not available
AG0958 Enterobacter cowanii s N Enterobacter cowanii 148
AG0959 Enterobacter cowanii s N Enterobacter cowanii 41/47
AG0960 Enterococcus g N Genus probe excluded
AG0961 Enterococcus durans s N Enterococcus durans 2976
Enterococcus faecalis s
AG0963 Enterococcus faecium s Y >7500 peak
AG0962 Enterococcus faecium s N Enterococcus faecium 6299
AG0964 Enterococcus saccharolyticus s N Enterococcus saccharolyticus no signal X 2
AG0965 Enterococcus saccharolyticus s N Enterococcus saccharolyticus no signal X 2
AG0966 Enterococcus saccharolyticus s N Enterococcus saccharolyticus 190
AG0968 Escherichia g N Citrobacter youngae                                     1533/751Cronobacter sakazakii 4248
Enterobacter 
cancerogenus 3031
Enterobacter 
cowanii 6152 Escherichia coli 2444
Escherichia 
fergusonii 3841
Salmonella 
enteritidis 
2610/1
260/87
2
AG0972 Escherichia g N Citrobacter youngae                                  3010/ 1035 Cronobacter sakazakii 8392 Enterobacter cowanii 8399 Escherichia coli 8627
Escherichia 
fergusonii 8405
Serratia 
marcescens 6357
AG0967 Escherichia g N Citrobacter diversus 4369 Citrobacter youngae 341/520/1343/832 Cronobacter sakazakii 5756
Enterobacter 
cancerogenus 2634 Enterobacter cowanii no signal Escherichia coli 2094
Escherichia 
fergusonii 2909
AG0975 Eubacterium biforme s N Eubacterium biforme 365/776
AG0980 Eubacterium biforme s Y 436 peak
AG0974 Eubacterium biforme s N Eubacterium biforme 794
AG0983 Eubacterium cylindroides s N Eubacterium cylindroides 2289/919/872 Eubacterium cylindroides
AG0985 Eubacterium cylindroides s N Eubacterium cylindroides 1377/784/476 Eubacterium cylindroides
AG0986 Eubacterium cylindroides s N Eubacterium cylindroides 885/1130/745 Eubacterium cylindroides
AG0995 Eubacterium gr 1 g N Genus probe excluded
AG0996 Eubacterium gr 2 g N Genus probe excluded
AG0999 Eubacterium gr 2 g N Genus probe excluded
AG1002 Eubacterium gr 2 g N Genus probe excluded
Eubacterium rectale      s
Faecalibacterium prausnitzii      s
AG1007 Fusobacterium g N Fusobacterium gonidiaformans 157 Fusobacterium mortiferum 228
Fusobacterium 
necrophorum subsp 
funduliforme 800
Fusobacterium 
nucleatum 500
Fusobacterium 
ulcerans 794
Fusobacterium 
varium no signal
AG1017 Gammaproteobacteria c N Target bacterium not available
AG1018 Gammaproteobacteria c N Target bacterium not available
AG1020 Gammaproteobacteria c N Target bacterium not available
AG1021 Haemophilus g N Haemophilus aphrophilus 3547  Haemophilus influenzae 2781 Mannheimia glucosida 3742
Mannheimia 
haemolytica 4550
AG1022 Haemophilus g N Haemophilus aphrophilus 1369  Haemophilus influenzae 367 Mannheimia glucosida 1721
Mannheimia 
haemolytica 1585
AG1232 Helicobacter g N Genus probe excluded
AG1023 Helicobacter bilis s N 100 peak at 100 bp Helicobacter bilis 30
AG1024 Helicobacter canis s N Helicobacter canis 3483
AG1026 Helicobacter ganmani s N Target bacterium not available
AG1028 Helicobacter ganmani s N Target bacterium not available
AG1029 Helicobacter ganmani s N Target bacterium not available
AG1030 Helicobacter hepaticus s N Helicobacter hepaticus 2359
AG1031 Helicobacter trogontum s N Helicobacter trogontum 2650
AG1032 Helicobacter trogontum s N Helicobacter trogontum 6919
AG1033 Klebsiella pneumoniae s N Klebsiella pneumoniae 1975
AG1034 Lachnospiraceae Incertae Sedis - N  Clostridium aminophilum 3794  Coprococcus eutactus 2309 Eubacterium hallii 1383 Eubacterium rectale 2082  Roseburia hominis 1680
Clostridium 
aldenense 890
Clostridium 
saccharolyticum 2504
Coprococcus 
comes 2502
AG1035 Lachnospira pectinoschiza s N 100 peak at 100bp Target bacterium not available
AG1036 Lachnospira pectinoschiza s N Target bacterium not available
AG1038 Lachnospiraceae bacterium A4 s N small peak at >100 bp Target bacterium not available
AG1039 Lachnospiraceae bacterium A4 s N Target bacterium not available
AG1042 Lachnospiraceae bacterium A4 s N Target bacterium not available
AG1045 Lactobacillus g N 130 peak at >100 bp Genus probe excluded
AG1046 Lactobacillus acidophilus s N Lactobacillus acidophilus 2404
AG1047 Lactobacillus fermentum s Y
8298 peak at 12 bp + 79 
bp
AG1048 Lactobacillus fermentum s N peak 1000 at >100 bp Lactobacillus fermentum 1171/379
AG1049 Lactobacillus fermentum s N peak 150 >100 bp Lactobacillus fermentum 1966/1068
AG1051 Lactobacillus johnsonii s N Lactobacillus johnsonii 3852
AG1052 Lactobacillus johnsonii s N Lactobacillus johnsonii 1779
AG1056 Lactobacillus johnsonii s N Lactobacillus johnsonii 242
AG1057 Lactobacillus reuteri s N Lactobacillus reuteri 972
AG1058 Lactobacillus ruminis s N Lactobacillus ruminis 3859
AG1060 Lactobacillus ruminis s N Lactobacillus ruminis 2289
AG1061 Lactobacillus ruminis s N Lactobacillus ruminis 2725
AG1062 Listeria g N Genus probe excluded
AG1063 Listeria g Y 183 peak at 25 bp Listeria innocua 8057 Listeria ivanovii 5728  Listeria seeligeri 4678
Listeria 
monocytogenes 6618  Listeria welshimeri 6078
AG1064 Listeria monocytogenes s N Listeria monocytogenes 7234
AG1065 Mannheimia g Y 3000 peak at 30 bp Mannheimia glucosida 3430 Mannheimia haemolytica 8215
AG1069 Mannheimia g Y 1000 peak at 30 bp Mannheimia glucosida 8200 Mannheimia haemolytica 8563
AG1066 Mannheimia g N Mannheimia glucosida 7351 Mannheimia haemolytica no signal
AG1072 Nocardioides sp. NS27 s N Target bacterium not available
AG1075 Nocardioides sp. NS27 s N Target bacterium not available
AG1076 Nocardioides sp. NS27 s N
two peaks at 80 bp and 
90 bp Target bacterium not available
AG1084 Novosphingobium sp. K39 s N Target bacterium not available
AG1086 Novosphingobium sp. K39 s N Target bacterium not available
AG1089 Novosphingobium sp. K39 s N Target bacterium not available
AG1094 Oscillibacter valericigenes s N Oscillibacter valericigenes 1054
AG1096 Oscillibacter valericigenes s N Oscillibacter valericigenes 1471
AG1097 Oscillibacter valericigenes s N Oscillibacter valericigenes 2506
AG1098 Oscillospira guilliermondii s Y 400 peak at 22 bp Target bacterium not available
AG1099 Parabacteroides g N Genus probe excluded
AG1100 Parabacteroides g N Genus probe excluded
AG1101 Prevotella g N Genus probe excluded
AG1102 Prevotella g N Genus probe excluded
AG1105 Prevotella bivia s N Prevotella bivia 4073
AG1106 Prevotella bivia s N Prevotella bivia 3063
AG1104 Prevotella bivia s N Prevotella bivia 6727
AG1110 Prevotella intermedia s N Prevotella intermedia 958/869 Prevotella intermedia
AG1112 Prevotella intermedia s N Prevotella intermedia 1368/1213 Prevotella intermedia
AG1113 Prevotella intermedia s N Prevotella intermedia 32 Prevotella intermedia
AG1115 Prevotella nigrescens s N Prevotella nigrescens 951
AG1116 Prevotella nigrescens s N Prevotella nigrescens 1089
AG1119 Prevotella ruminicola s N Target bacterium not available
AG1124 Prevotella ruminicola s N Target bacterium not available
AG1125 Prevotella ruminicola s N Target bacterium not available
AG1128 Proteus vulgaris s Y Tested in MFA study
AG1129 Proteus vulgaris s N Tested in MFA study P. mirabilis no signal P. vulgaris 16
AG1132 Proteus vulgaris s N Tested in MFA study P. mirabilis no signal P. vulgaris no signal
AG1133 Pseudomonas straminea s N Pseudomonas straminea 8504
AG1134 Pseudomonas straminea s N Pseudomonas straminea 3723
AG1135 Roseburia g N Genus probe excluded
AG1138 Roseburia g N Genus probe excluded
AG1139 Roseburia cecicola s N Target bacterium not available
AG1140 Roseburia cecicola s N Target bacterium not available
AG1143 Roseburia cecicola s N Target bacterium not available
AG1147 Roseburia hominis s N Roseburia hominis 369
AG1146 Roseburia hominis s - no signal Roseburia hominis 5829
AG1173 Ruminococcus g N Genus probe excluded
AG1174 Ruminococcus g N Genus probe excluded
AG1151 Ruminococcus albus s N Ruminococcus albus 5655
AG1148 Ruminococcus albus s N Ruminococcus albus 5405
AG1150 Ruminococcus albus s N Ruminococcus albus 2142
AG1153 Ruminococcus bromii s N Ruminococcus bromii 224
AG1154 Ruminococcus bromii s N Ruminococcus bromii 148
Ruminococcus bromii       s
AG1152 Ruminococcus bromii L263 s N Ruminococcus bromii 7871
AG1157 Ruminococcus callidus s N 70 peak at 70 bp Target bacterium not available
AG1163 Ruminococcus callidus s N 50 peak at 25 bp Target bacterium not available
AG1167 Ruminococcus callidus s N Target bacterium not available
Ruminococcus gnavus s
Ruminococcus obeum     s
Ruminococcus torques s
AG1175 Shigella g N 150 peak at  >100 bp  Escherichia coli 1500  Escherichia fergusonii 1500 Salmonella bongori no signal Shigella flexneri 1156 Shigella sonnei 1450
AG1176 Sphingomonas g Y peak 6700 Genus probe excluded
AG1180 Sphingomonas paucimobilis s N Sphingomonas paucimobilis 37
AG1182 Sphingomonas paucimobilis s N Sphingomonas paucimobilis 41/33
AG1184 Sphingomonas paucimobilis s N Sphingomonas paucimobilis 46
AG1235 Sphingomonas sp. AO1 g N Target bacterium not available
AG1236 Sphingomonas sp. AO1 g N Target bacterium not available
AG1237 Sphingomonas sp. AO1 g N Target bacterium not available
Subdoligranulum g
AG1199 Sutterella wadsworthensis s N Sutterella wadsworthensis 356/674/1351 Sutterella wadsworthensis
AG1201 Sutterella wadsworthensis s N Sutterella wadsworthensis 4271/1767/1986 Sutterella wadsworthensis
AG1203 Sutterella wadsworthensis s N Sutterella wadsworthensis 1673/900/464 Sutterella wadsworthensis
AG1211 Veillonella g Y peak 200 at >100 bp
AG1207 Veillonella g N  Veillonella dispar 3791
AG1209 Veillonella g N  Veillonella dispar 1500
AG1214 Vibrio campbellii s N Vibrio campbellii 1195/1822/1636 Vibrio campbellii
AG1215 Wolinella succinogenes s N peak 90 at 90 bp Wolinella succinogenes 1413/1598/1030 Wolinella succinogenes
AG1216 Wolinella succinogenes s N Wolinella succinogenes 1846/1377/741 Wolinella succinogenes
APPENDIX K – Probe overview from capillary gel electrophoresis (non-target)
Color code: Blue - optimal probe. Yellow - excluded due to self-hybrid, double top, weak signal. Green - tested at GA before. Grey - excluded, bacterium not available. Pink - problem with LIZ or signal under cut-off
Phyla: Genus(g), Species(s), Class(c)
Color code ID Target info Phyla Non-target 1 Sign non-t. 1 Non-target 2 Sign. 2 Non-target 3 Sign. 3 Non-target 4 Sign. 4 Non-target 5 Sign.. 5 Non-target 6 Sign. 6 Non-target 7 Sign. 7 Non-target 8 Sign. 8 Non-target 9 Sign. 9 Non-target 10 Sign. 10 Non-target 11 Sign. 11
AG0770 Acidimicrobidae bacterium Ellin s
AG0774 Acidimicrobidae bacterium Ellin s
AG0775 Acidimicrobidae bacterium Ellin s
AG0777 Acinetobacter junii s Pseudomonas straminea 53
AG0784 Acinetobacter junii s Pseudomonas straminea 40
AG0783 Acinetobacter junii s Pseudomonas straminea 62
AG0792 Aeromonas g
AG0793 Aeromonas g Dorea longicatena 45 Campylobacter coli        no signal
AG0815 Akkermansia muciniphila s Clostridium sp. SS2-1         no signal
AG0798 Akkermansia muciniphila s Clostridium sp. SS2/1 51
AG0801 Akkermansia muciniphila s Clostridium sp. SS2/1 66
AG1226 Alistipes g
AG1225 Alistipes onderdonkii s Alistipes putredinis 32
Alistipes putredinis s
AG0819 Asteroleplasma g
AG0827 Asteroleplasma g
AG0829 Asteroleplasma g
AG0848 Bacillus g
AG0849 Bacillus licheniformis s Bacillus alcalophilus 31
AG0850 Bacillus licheniformis s Bacillus alcalophilus          94 (7bp)
AG0851 Bacillus megaterium s Listeria monocytogenes        124 (7bp)
AG0852 Bacillus megaterium s Listeria monocytogenes 50
AG0854 Bacillus megaterium s Listeria monocytogenes 80
AG0856 Bacterium mpn-isolate group 5 s
AG0857 Bacterium mpn-isolate group 5 s
AG0858 Bacterium mpn-isolate group 5 s
AG0859 Bacteroides acidofaciens s Bacteroides stercoris 48
AG0860 Bacteroides acidofaciens s Bacteroides stercoris 30
AG0861 Bacteroides acidofaciens s Bacteroides coprophilus 44
(Para) bacteroides distasonis s
Bacteroides fragilis s
Bacteroides ovatus s
Bacteroides stercoris s
Bacteroides thetaiotaomicron s
Bacteroides uniformis s
Bacteroides vulgatus s
AG0862 Bacteroides zoogleoformans s Bacteroides coprophilus 37
AG0863 Bacteroides zoogleoformans s Bacteroides coprophilus       125 (7 bp)
AG0864 Bifidobacterium g
AG0865 Bifidobacterium g Megamonas hypermegale 37
Clostridium 
saccharolyticum 48 Desulfovibrio piger 52 Clostridium ramosum 34
Actinomyces 
odontolyticus 45
Collinsella 
aerofaciens 57 Collinsella tanakaei 53
Gordonibacter 
pamelaeae 44
Campylobacter 
concisus 59
Vibrio 
metschnikovii 75
Helicobacter 
canis 45
AG0867 Bifidobacterium adolescentis s Bifidobacterium infantis 37
AG0868 Bifidobacterium adolescentis s Bifidobacterium infantis 99
AG0870 Bifidobacterium bifidum s Bifidobacterium dentium         no signal
AG0871 Bifidobacterium bifidum s Bifidobacterium dentium 1504
AG0872 Bifidobacterium infantis s Bifidobacterium animalis 32
AG0873 Bifidobacterium infantis s Bifidobacterium animalis 38
AG0876 Bifidobacterium infantis s Bifidobacterium animalis 814
AG1224 Blautia g
AG1230 Blautia g
AG0878 Blautia coccoides s Ruminococcus gnavus 39
AG0879 Blautia coccoides s Ruminococcus obeum 35
AG1227 Blautia schinkii s Collinsella tanakaei 39
AG1228 Blautia schinkii s Collinsella tanakaei         no signal
AG1229 Blautia schinkii s Collinsella tanakaei         no signal
AG0880 Butyrivibrio fibrisolvens s Coprococcus comes 36
AG0881 Butyrivibrio fibrisolvens s Coprococcus comes 71
AG0884 Butyrivibrio fibrisolvens s Coprococcus comes 48
AG0886 Campylobacter g Vibrio metschnikovii         no signal Helicobacter canis no signal
Subdoligranulum 
variabile 35
Streptococcus 
thermophilus 41 Helicobacter bilis 30
Wolinella 
succinogenes 1346/355
AG0893 Catenibacterium mitsuokai s Lactobacillus ultunensis 31
AG0895 Catenibacterium mitsuokai s Lactobacillus ultunensis         no signal
AG0894 Catenibacterium mitsuokai s Lactobacillus ultunensis 38
AG0896 Citrobacter g Ruminococcus torques Proteus vulgaris 79
AG0898 Clostridium  gr 2 g Coprococcus comes
Coprococcus 
eutactus
AG0899 Clostridium aminophilum s Ruminococcus obeum 51
AG0900 Clostridium aminophilum s Ruminococcus obeum 38
AG0902 Clostridium clostridioforme s Clostridium asparagiforme 33
AG0903 Clostridium clostridioforme s Clostridium asparagiforme         no signal
AG0905 Clostridium difficile s Pediococcus acidilactici 37
AG0907 Clostridium difficile s Pediococcus acidilactici 32
AG0908 Clostridium difficile s Pediococcus acidilactici 33
AG0897 Clostridium gr 1 g Coprococcus comes
Coprococcus 
eutactus
Clostridium leptum       s
AG1231 Clostridium limosum s Clostridium histolyticum         no signal
AG0910 Clostridium lituseburense s Clostridium scindens 91
AG0911 Clostridium lituseburense s Clostridium scindens 39
AG0912 Clostridium methylpentosum s Clostridium hiranonis 36
AG0913 Clostridium methylpentosum s Clostridium hiranonis 32
Clostridium nexile      s
AG0914 Clostridium orbiscindens s Bacteroides capillosus 210
AG0915 Clostridium orbiscindens s Bacteroides capillosus 30
AG0917 Clostridium ramosum s Catenibacterium mitsuokai         no signal
AG0916 Clostridium ramosum s Catenibacterium mitsuokai         no signal
AG0918 Clostridium ramosum s Catenibacterium mitsuokai         no signal
AG1221 Clostridium sp. SS2-1 s Coprcoccus eutactus 37
AG1223 Clostridium sp. SS2-1 s Coprcoccus eutactus         no signal
AG1219 Clostridium sp. SS2-1 s Coprcoccus eutactus 45
AG0922 Clostridium viride s Clostridium orbiscindens
AG0919 Clostridium viride s Clostridium orbiscindens 1261
AG0921 Clostridium viride s Clostridium orbiscindens 1524
AG0924 Clostridium xylanolyticum s Clostridium bolteae         no signal
AG0925 Clostridium xylanolyticum s Clostridium bolteae 65
Coprococcus g
AG0926 Dialister g
AG0928 Dialister g
AG0930 Dialister g
AG0932 Dialister invisus s Catenibacterium mitsuokai         no signal
AG0931 Dialister invisus s Catenibacterium mitsuokai 31
AG0938 Dorea g
Dorea formicigenerans s
Dorea longicatena s
AG0939 Drinking water bacterium Y7 s
AG0942 Drinking water bacterium Y7 s
AG0948 Drinking water bacterium Y7 s
AG0958 Enterobacter cowanii s Ruminococcus torques         no signal
AG0959 Enterobacter cowanii s Ruminococcus torques 33
AG0960 Enterococcus g
AG0961 Enterococcus durans s Vibrio cholerae 4331
Enterococcus faecalis s
AG0963 Enterococcus faecium s
AG0962 Enterococcus faecium s Enterococcus durans 5750
AG0964 Enterococcus saccharolyticus s Enterococcus faecium 35
AG0965 Enterococcus saccharolyticus s Enterococcus faecium 53
AG0966 Enterococcus saccharolyticus s Enterococcus faecium 85
AG0968 Escherichia g Citrobacter amalonaticus 7285 Edwardsiella tarda 6315 Citrobacter diversus 6631 Helicobacter canis 0 Prevotella oris 0
Helicobacter 
hepaticus 40 Aeromonas caviae 30
AG0972 Escherichia g Ruminococcus bromii         no signal
Citrobacter 
amalonaticus 7840
Dorea 
formicigenerans 105 Helicobacter canis 38
Helicobacter 
cinaedi 0
Dorea 
longicatena 119
AG0967 Escherichia g Helicobacter cinaedi         no signal
Prevotella 
nigrescens 32
Citrobacter 
amalonaticus 1638 Roseburia hominis 0 Prevotella oris 0
Prevotella 
intermedia 38
Ruminococcus 
bromii 0
AG0975 Eubacterium biforme s Sutterella wadsworthensis 1610
AG0980 Eubacterium biforme s
AG0974 Eubacterium biforme s Sutterella wadsworthensis 1024
AG0983 Eubacterium cylindroides s Sutterella wadsworthensis 1685
AG0985 Eubacterium cylindroides s Sutterella wadsworthensis 2019
AG0986 Eubacterium cylindroides s Sutterella wadsworthensis 1678
AG0995 Eubacterium gr 1 g
AG0996 Eubacterium gr 2 g
AG0999 Eubacterium gr 2 g
AG1002 Eubacterium gr 2 g
Eubacterium rectale      s
Faecalibacterium prausnitzii      s
AG1007 Fusobacterium g Anaerococcus hydrogenalis 35 Finegoldia magna 34
Streptococcus 
thermophilus 0 Listeria welshimeri 32
Streptococcus 
subsp infantarius 32
Campylobacter 
coli 0
AG1017 Gammaproteobacteria c
AG1018 Gammaproteobacteria c
AG1020 Gammaproteobacteria c
AG1021 Haemophilus g Vibrio campbellii 1251 Vibrio cholerae 110
Vibrio 
metschnikovii 147 Aeromonas veronii 40
AG1022 Haemophilus g Vibrio campbellii       1383/617 Vibrio cholerae 30
Vibrio 
metschnikovii 52 Aeromonas caviae 0
AG1232 Helicobacter g
AG1023 Helicobacter bilis s Helicobacter canis         no signal
AG1024 Helicobacter canis s Helicobacter cinaedi 34
AG1026 Helicobacter ganmani s
AG1028 Helicobacter ganmani s
AG1029 Helicobacter ganmani s
AG1030 Helicobacter hepaticus s Helicobacter bilis 92
AG1031 Helicobacter trogontum s Helicobacter canis 1922
AG1032 Helicobacter trogontum s Helicobacter hepaticus 226
AG1033 Klebsiella pneumoniae s Klebsiella oxytoca 229
AG1034 Lachnospiraceae Incertae Sedis - Holdemania filiformis 31
Klebsiella 
pneumoniae 223
Clostridium 
bartlettii 39 Blautia Coccoides 1721/771
Clostridium 
methylpentosum 31
Helicobacter 
canis 39/114
Enterobacter 
cowanii 155
Collinsella 
aerofaciens 30
AG1035 Lachnospira pectinoschiza s
AG1036 Lachnospira pectinoschiza s
AG1038 Lachnospiraceae bacterium A4 s
AG1039 Lachnospiraceae bacterium A4 s
AG1042 Lachnospiraceae bacterium A4 s
AG1045 Lactobacillus g
AG1046 Lactobacillus acidophilus s Lactobacillus buchneri 45
AG1047 Lactobacillus fermentum s
AG1048 Lactobacillus fermentum s Lactobacillus crispatus 126
AG1049 Lactobacillus fermentum s Lactobacillus crispatus 3855
AG1051 Lactobacillus johnsonii s Listeria seeligeri                              no signal
AG1052 Lactobacillus johnsonii s Listeria seeligeri                              no signal
AG1056 Lactobacillus johnsonii s Listeria seeligeri 34
AG1057 Lactobacillus reuteri s Lactobacillus fermentum 1113
AG1058 Lactobacillus ruminis s Enterococcus faecalis                             no signal
AG1060 Lactobacillus ruminis s Enterococcus faecalis 85
AG1061 Lactobacillus ruminis s Enterococcus faecalis 36
AG1062 Listeria g
AG1063 Listeria g Lactobacillus johnsonii 65
Bacillus 
megaterium 94
Enterococcus 
faecalis 150 Listeria grayi 497
Lactobacillus 
paracasei 118
AG1064 Listeria monocytogenes s Lactobacillus johnsonii                             no signal
AG1065 Mannheimia g Vibrio furnissii 4093
Haemophilus 
paraphrophilus 6405
AG1069 Mannheimia g Vibrio furnissii 2836
Haemophilus 
paraphrophilus 3259
AG1066 Mannheimia g Vibrio furnissii 52
Haemophilus 
paraphrophilus 35
AG1072 Nocardioides sp. NS27 s
AG1075 Nocardioides sp. NS27 s
AG1076 Nocardioides sp. NS27 s
AG1084 Novosphingobium sp. K39 s
AG1086 Novosphingobium sp. K39 s
AG1089 Novosphingobium sp. K39 s
AG1094 Oscillibacter valericigenes s Clostridium orbiscindens 1005
AG1096 Oscillibacter valericigenes s Clostridium orbiscindens 1168
AG1097 Oscillibacter valericigenes s Clostridium orbiscindens 2866
AG1098 Oscillospira guilliermondii s
AG1099 Parabacteroides g
AG1100 Parabacteroides g
AG1101 Prevotella g
AG1102 Prevotella g
AG1105 Prevotella bivia s Alistipes putredinis         no signal
AG1106 Prevotella bivia s Alistipes putredinis         no signal
AG1104 Prevotella bivia s Alistipes putredinis 40
AG1110 Prevotella intermedia s Prevotella nigrescens        1004/966
AG1112 Prevotella intermedia s Prevotella nigrescens 36
AG1113 Prevotella intermedia s Prevotella nigrescens         no signal
AG1115 Prevotella nigrescens s Prevotella intermedia          441/168  
AG1116 Prevotella nigrescens s Prevotella intermedia        1174/822
AG1119 Prevotella ruminicola s
AG1124 Prevotella ruminicola s
AG1125 Prevotella ruminicola s
AG1128 Proteus vulgaris s
AG1129 Proteus vulgaris s Enterobacter cancerogenus 950
Klebsiella 
pneumoniae 491
Holdemania 
filiformis 0
AG1132 Proteus vulgaris s Enterobacter cancerogenus 5141
Klebsiella 
pneumoniae no signal
Holdemania 
filiformis 0
AG1133 Pseudomonas straminea s Acinetobacter junii 96
AG1134 Pseudomonas straminea s Acinetobacter junii 173
AG1135 Roseburia g
AG1138 Roseburia g
AG1139 Roseburia cecicola s
AG1140 Roseburia cecicola s
AG1143 Roseburia cecicola s
AG1147 Roseburia hominis s Ruminococcus obeum 69
AG1146 Roseburia hominis s Ruminococcus obeum 29
AG1173 Ruminococcus g
AG1174 Ruminococcus g
AG1151 Ruminococcus albus s Clostridium methylpentosum         no signal
AG1148 Ruminococcus albus s Clostridium methylpentosum 34
AG1150 Ruminococcus albus s Clostridium methylpentosum 33
AG1153 Ruminococcus bromii s Clostridium methylpentosum 230
AG1154 Ruminococcus bromii s Clostridium methylpentosum         no signal
Ruminococcus bromii       s
AG1152 Ruminococcus bromii L263 s Clostridium methylpentosum 99
AG1157 Ruminococcus callidus s
AG1163 Ruminococcus callidus s
AG1167 Ruminococcus callidus s
Ruminococcus gnavus s
Ruminococcus obeum     s
Ruminococcus torques s
AG1175 Shigella g Ruminococcus torques 42
Citrobacter 
amalonaticus 223/274
Klebsiella 
pneumoniae 0 Citrobacter youngae
413/455/1
047
Helicobacter 
trogontum 0
AG1176 Sphingomonas g
AG1180 Sphingomonas paucimobilis s
Corynebacterium 
ammoniagenes 30
AG1182 Sphingomonas paucimobilis s
Corynebacterium 
ammoniagenes 60
AG1184 Sphingomonas paucimobilis s
Corynebacterium 
ammoniagenes 44
AG1235 Sphingomonas sp. AO1 g
AG1236 Sphingomonas sp. AO1 g
AG1237 Sphingomonas sp. AO1 g
Subdoligranulum g
AG1199 Sutterella wadsworthensis s Faecalibacterium prausnitzii 34
AG1201 Sutterella wadsworthensis s Faecalibacterium prausnitzii 53
AG1203 Sutterella wadsworthensis s Faecalibacterium prausnitzii              48/77
AG1211 Veillonella g
AG1207 Veillonella g Dialister invisus         no signal
AG1209 Veillonella g Dialister invisus         no signal
AG1214 Vibrio campbellii s Vibrio mimicus 40
AG1215 Wolinella succinogenes s Campylobacter curvus 33
AG1216 Wolinella succinogenes s Campylobacter curvus 31
APPENDIX L – Relatedness of bacteria presented in GA-mapTM IBD assay 
 
 
Target group - species Probe ID  Phylum Class Order  Family Genus 
Akkermansia muciniphila AG0798 Verrucomicrobia Verrucomicrobiae Verrucomicrobiales Verrucomicrobiaceae Akkermansia 
Catenibacterium mitsuokai AG0894 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Catenibacterium 
Clostridium aminophilum AG0899 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium 
Clostridium difficile AG0907 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium 
Clostridium methylpentosum AG0912 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium 
Clostridium ramosum IG0013 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium 
Dialister invisus AG0931 Firmicutes Negativicutes  Selenomonadales Veillonellaceae Dialister 
Fusobacterium periodonticum IG0113 Fusobacteria Fusobacteriia Fusobacterales Fusobacteriaceae Fusobacterium 
Haemophilus (genus) AG1021 Proteobacteria Gammaproteobac. Pasteurellales Pasteurellaceae Haemophilus 
Lactobacillus johnsonii AG1051 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 
Lactobacillus ruminis AG1058 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 
Pseudomonas straminea AG1133 Proteobacteria Gammaproteobac. Pseudomonadales Pseudomonadaceae Pseudomonas 
Ruminococcus albus AG1148 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus 
Veillonella (genus) AG1207 Firmicutes Negativicutes Selenomonadales Veillonellaceae Veillonella 
Bifidobacteria AG1219 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 
Alistipes putredinis AG0339 Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes 
Bacteroides fragilis AG0377 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 
Bacteroides stercoris AG0416 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 
Clostridium leptum        AG0470 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium 
Coprococcus comes AG0495 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus 
Coprococcus eutactus AG0569 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus 
Dorea formicigenerans AG0581 Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea 
Enterococcus faecalis AG0591 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus 
Eubacterium rectale       AG0620 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium 
Faecalibacterium prausnitzii       AG0651 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium 
Ruminococcus gnavus AG0703 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus 
Subdoligranulum (genus) AG0744 Firmicutes Clostridia Clostridiales Ruminococcaceae Subdoligranulum 
Bacillus licheniformis AG0849 Firmicutes Bacilli Bacillales Bacillaceae Bacillus 
Bacteroides acidofaciens AG0861 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 
Enterococcus faecium AG0962 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus 
Eubacterium biforme AG0974 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Eubacterium 
Helicobacter canis AG1024 Proteobacteria Epsilonproteobact. Campylobacterales Helicobacteraceae Helicobacter 
Helicobacter hepaticus AG1030 Proteobacteria Epsilonproteobact. Campylobacterales Helicobacteraceae Helicobacter 
Klebsiella pneumoniae AG1033 Proteobacteria Gammaproteobac. Enterobacteriales Enterobacteriaceae Klebsiella 
Lactobacillus reuteri AG1057 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 
Mannheimia (genus) AG1066 Proteobacteria Gammaproteobac. Pasteurellales Pasteurellaceae Mannheimia 
Blautia schinkii AG1228 Firmicutes Clostridia Clostridiales - Blautia 
Proteobacteria (phylum) IG0005 Proteobacteria     
Haemophilus parainfluenza IG0008 Proteobacteria Gammaproteobac. Pasteurellales Pasteurellaceae Haemophilus 
Firmicutes 1  (phylum)   IG0012 Firmicutes     
Firmicutes 2  (phylum) IG0023 Firmicutes     
Gammaproteobacteria (class) IG0056 Proteobacteria  Gammaproteobac.    
Bacteroides (genus) IG0060 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 
E.coli/Shigella IG0133 Proteobacteria Gammaproteobac. Enterobacteriales Enterobacteriaceae Escherichia/ Shigella 
Blautia coccoides/Clostridium 
coccoides 
AG0879 Firmicutes Clostridia Clostridiales  Blauti/ coccoides 
Roseburia hominis AG1146 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia 
Ruminococcus bromii L263 AG1152 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus 
Bifidobacteria IG0028 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 
Enterococcus (genus) IG0014 Firmicutes Bacilli Lactobacillales Enterococcaceae  
Universal probe UNI05      
 !
